Abstract
Ischemic stroke is one of the leading causes of death and long-term disability worldwide. A significant proportion of stroke survivors experience persistent motor impairments, which severely affect their quality of life and cause heavy social and economic burdens. Acupuncture has increasingly gained attention due to its remarkable efficacy in promoting motor function recovery after stroke, and it has been progressively endorsed as a post-stroke treatment option by clinical guidelines of numerous countries, despite its underlying mechanism is not yet fully understood. This review systematically evaluates existing basic and clinical studies to explore the potential mechanisms of acupuncture’s effects on motor function recovery after ischemic stroke and the optimal clinical strategies. Emerging evidence demonstrates that acupuncture-mediated post-stroke motor recovery is primarily attributed to its roles in restoring energy metabolism, inhibiting neuroinflammation, preventing neuronal apoptosis, promoting neuronal repair and regeneration, and regulating neuronal excitability. Additionally, individualized acupuncture modality involving syndrome-based selection of acupoints and stimulating methods is crucial for better rehabilitation outcome. Our findings elucidate the multidimensional impacts of acupuncture on motor function restoration following ischemic stroke, furnishing robust evidence and theoretical foundation for its clinical application.
1 Introduction
Stroke is a cerebrovascular disease that usually leads to localized damage to the central nervous system due to either blocked blood supply to the brain (ischemic stroke) or cerebral hemorrhage (hemorrhagic stroke), with ischemic stroke accounting for 76% of all cases (Virani et al., 2021). According to the latest global health statistics, stroke remains the second leading cause of death worldwide and is a major factor leading to permanent disability (GBD 2019 Stroke Collaborators, 2021). As the population ages and lifestyle changes, the incidence of stroke continues to rise, which has become a major challenge to global public health. More than two-thirds of stroke patients continue to experience varying degrees of motor function impairment after the acute phase (Handley et al., 2009; Wissel et al., 2013), which undermines their ability to live independently, severely impacts their quality of life and subsequently increases social and economic burdens (Gong et al., 2022). Although some patients achieve partial motor recovery through neural remodeling and compensation, those with severe injuries often evolve into permanent disability (Dimyan and Cohen, 2011). Consequently, motor function recovery is the primary focus of post-stroke rehabilitation.
Due to the complex manifestations of motor impairments after ischemic stroke, no clear management strategies have been established. Drug therapy is a common treatment, for example, baclofen and botulinum toxin for hypertonia, while haloperidol and diazepam are employed to control tremor and hemichorea-hemiballism (Creamer et al., 2018; Ristic et al., 2002; Gracies et al., 2015). Yet, such efficacy is generally confined to transient alleviation of symptoms. Stroke survivors often require long-term medication, which may lead to drug dependence and resistance, as well as a range of adverse reactions, including potential toxicity to liver and kidney (Falcone et al., 2024). Rehabilitation also represents a central strategy, such as the combination of task-specific training and general aerobic exercise (Dimyan and Cohen, 2011; Nudo et al., 1996; Taub et al., 2002). Despite this established approach, its overall effectiveness remains limited, as 15%–30% of patients continue to experience permanent disability even after intensive training and sustained physical activity (Lloyd-Jones et al., 2009). With advances in technology, particularly the support of nanotechnology, some new therapies have been proposed. Particularly the neural stem cell (NSC) therapy and exogenous material-based replacement therapy have shown preliminary preclinical success in promoting neural tissue regeneration (Lindvall and Kokaia, 2010; Zhong et al., 2010; Waris et al., 2022; Lee et al., 2017). In addition, controlling neural prosthetics through brain-computer interfaces offers a new pathway, which bypasses the damaged neural pathways and thereby becomes a training tool to promote the remodeling and functional recovery of the nervous system (Daly and Wolpaw, 2008). Although these new therapies show great potential, they are still in the stage of small-scale research and have not yet been widely applied. Furthermore, these therapies are associated with high costs and technical challenges, which hinder their widespread adoption in clinical treatment.
Acupuncture has been widely employed for the management of stroke in China for several millennia, particularly in the restoration of limb motor function. The World Health Organization has recommended acupuncture as a complementary and alternative therapy for stroke sequelae (World Health Organization, 2002). Meanwhile, it has been progressively endorsed as a post-stroke treatment option by clinical guidelines of numerous countries (Birch and Robinson, 2022). Unlike drug therapy, acupuncture both alleviates individual symptoms and fundamentally promotes nerve repair and improves motor function through multi-target and multi-channel mechanisms, such as repairing the damaged neural network, and restoring the function of neural circuits (Li et al., 2024; Mu et al., 2023). Hence, acupuncture exhibits significant potential for both research exploration and clinical application.
This review focuses on motor function recovery after ischemic stroke and provides a comprehensive evaluation of existing basic and clinical studies on acupuncture. Basic studies are examined to illustrate the mechanism of acupuncture, providing a theoretical basis for its clinical application. In parallel, clinical evidence is evaluated to assess and compare efficacy of different acupuncture protocols, with the aim of providing more precise guidance for clinical practice.
2 Methods
We performed a comprehensive literature search in PubMed, Web of Science, and Embase, covering publications from the inception of each database up to the present time. The search was limited to studies published in English and focused on ischemic stroke. The following keywords were used in various combinations: acupuncture, electroacupuncture (EA), stroke, cerebral infarction, motor dysfunction, motor impairment, movement disorder and rehabilitation. Following a thorough assessment, the information furnished in the following studies has been elucidated and discussed in detail.
3 Overview of motor impairments after ischemic stroke
3.1 Neurophysiological modulation of motor function
The neural modulation of motor activities is a complex and precise process that relies on the cooperation of multiple components of the central nervous system. The motor cortex, located in the frontal lobe, is the origin of voluntary movement and is responsible for issuing motor commands and regulating movement (Ebbesen and Brecht, 2017). The motor cortex does not directly innervate muscles, instead, it regulates movement through complex neural pathways. Layer 5 pyramidal neurons in the primary motor cortex send projections via the corticospinal and corticobulbar tracts to the interneurons in the spinal cord and brainstem, which then precisely regulate movement by activating or inhibiting lower motor neuron activity (Lemon, 2008; Grinevich et al., 2005; O’Donoghue et al., 1987). Additionally, the motor cortex connects multiple cortical and subcortical structures through neural pathways, including the somatosensory cortex, basal ganglia, motor thalamus, brainstem, and cerebellum, to finely regulate motion (Kinnischtzke et al., 2014; Osten and Margrie, 2013). Meanwhile, the motor cortex receives input from the primary somatosensory cortex to optimize motor commands by integrating sensory information (Petrof et al., 2015; Ferezou et al., 2007).
The basal ganglia, located deep within the white matter of the brain, primarily regulate the timing and intensity of movement to ensure coordination and fluidity (Yttri and Dudman, 2016). The striatum is the largest input nucleus of the basal ganglia which receives signals from the frontal lobe, sensory and motor cortices, and related thalamic regions (Mcgeorge and Faull, 1989; Gremel and Costa, 2013; Li et al., 2015). It selects the most appropriate behavior after integrating internal states, environmental information, and exercise plans (Klaus et al., 2019). The striatum includes direct medium spiny neurons (dMSNs) and indirect medium spiny neurons (iMSNs). Sustained activation of dMSNs increases motion, whereas sustained activation of iMSNs decreases motion (Kravitz et al., 2010). By controlling the activities of these two types of neurons, the cortex flexibly regulates the initiation, inhibition, frequency, and intensity of movement to meet different demands (Gurney et al., 2015; Yttri and Dudman, 2016).
The cerebellum delicately regulates movement primarily through feedback circles with other brain regions to maintain the accuracy and stability of action (Kim et al., 2024). The cerebellum is crucial for motor control, coordination, and learning, with its diverse regions affecting movement through specific pathways (Morton and Bastian, 2004). The medial cerebellar region receives and integrates inputs from the spinal cord, brainstem, and vestibular system to regulate key motor pathways, such as the vestibulospinal and reticulospinal tracts, in order to maintain postural balance and trunk stability (Ilg et al., 2008; Matsushita and Okado, 1981). The middle cerebellar region receives inputs from the cortex, spinal cord, and reticular nucleus, and projects signals to the red nucleus and cortex after integrating motor information, thereby coordinating movement (Asanuma et al., 1983b; Asanuma et al., 1983a). The lateral cerebellar region receives dense projections from cortical regions and sends signals to the red nucleus and cortex, primarily controlling the walk to ensure the consistency and rhythmicity of movement (Dum and Strick, 2003).
The brainstem integrates motor control signals from brain and spinal cord, and directly regulates the spinal cord circuitry, thereby controlling the initiation, speed, halt, and direction of movement (Leiras et al., 2022). As a central hub for regulating motor initiation and gait, the midbrain locomotor region (MLR) receives inputs from the cerebral cortex, basal ganglia, and brainstem sensorimotor regulatory regions to coordinate autonomous exploratory behavior and escape responses by conveying motor signals to the spinal cord via the reticulospinal tract (Caggiano et al., 2018; Dautan et al., 2021). Thus, the precise modulation of spinal motor circuits is attained via the synergistic actions of the excitatory medial tract and the inhibitory lateral tract (Brownstone and Chopek, 2018).
As the final executive link in motor control, the spinal cord receives and integrates descending signals from the central nervous system and peripheral sensory feedback to coordinate and execute reflex and voluntary and rhythmic movements (Nielsen, 2016). The anterior horn is the convergence of motor neurons, which is responsible for transmitting motor commands to the surrounding muscles (Negro and Farina, 2011). The cortex regulates motor neurons in the anterior horn through descending neural pathways, such as the corticospinal tracts and reticulospinal tracts, so as to ensure timely and coordinated muscle activity, thereby optimizing movement and maintaining postural stability (Teka et al., 2017; Menon and Vucic, 2021). In addition, a large number of spinal interneurons, distributed in the gray matter of the spinal cord, constitute a complex motor regulation network (Côté et al., 2018). Spinal interneurons continuously receive peripheral sensory information from the spinal cord dorsal horn and integrate it with descending signals from higher centers to flexibly balance the excitability and inhibition of the anterior horn, further regulating movement.
3.2 Motor impairments after ischemic stroke
3.2.1 Neural structural damage
Although the brain accounts for only 2% of body weight, its energy demand accounts for 20% of the body’s total energy consumption (Sifat et al., 2022). Disruption of energy metabolism is a pathological feature of ischemic stroke (Yatsu et al., 1975). After ischemic stroke, brain tissue surrounding the occluded vessels becomes ischemic, and the blood flow in the core ischemic region is reduced by more than 80% (Back et al., 2004). This causes neurons to be damaged due to a sudden drop in energy supply (Lyden et al., 2019). Research has shown that among hemiplegic patients with hand dyskinesia after stroke, the ipsilateral thalamus displays severe metabolic inhibition, and thalamic metabolic activity correlates with the degree of motor function recovery, revealing the critical role of energy metabolism restoration in motor rehabilitation (Binkofski et al., 1996). Adenosine Triphosphate (ATP) exhaustion triggers ischemic cascade reactions, including failure of membrane ion pumps, cellular edema, and membrane depolarization (Lee et al., 2000; Hofmeijer and Van Putten, 2012). Neurons cannot maintain their normal transmembrane ion gradients, which triggers a series of pathophysiological processes, including excitotoxicity, mitochondrial dysfunction, oxidative and nitrative stress, neuroinflammation, protein misfolding, and apoptosis. These pathological mechanisms form a vicious cycle, ultimately leading to cell death (He Z. et al., 2020).
Chemokines, reactive oxygen species, and other factors produced by the ischemic cascade reaction trigger immune responses in the nervous system (Larrea et al., 2023). Persistent inflammation expands the extent of brain injury and severely impacts motor function after stroke (Larrea et al., 2023; Lukacova et al., 2021). Neuroinflammation directly damages local tissues in the early stages. Moreover, it promotes glial scar formation and inhibits neuronal regeneration, leading to long-term neuronal damage (Nishimura et al., 2007; Beck and Yaari, 2008). This further impairs motor function and eventually leads to chronic and persistent disability (Larrea et al., 2023; Min et al., 2012). Research confirms that excessive microglial activation after stroke significantly worsens motor function damage, which suggests that relieving neuroinflammation is crucial for recovering motor function after stroke (Lartey et al., 2014).
Disruption of energy metabolism and subsequent initiation of inflammation together lead to cellular dysfunction and apoptosis (Zhou et al., 2021; Pascotini et al., 2015). Extensive apoptosis occurs in the motor cortex, basal ganglia, and other motor control-related regions, causing disruption of the structure and function of motor circuits and ultimately leads to motor impairments. One study shows that early motor rehabilitation after ischemic stroke can protect neurons and promote the recovery of coordinated forelimb motor function by inhibiting neuronal apoptosis in middle cerebral artery occlusion (MCAO) rats (Zhang et al., 2013).
3.2.2 Motor impairment
A complete neural structure is essential for the proper functioning of nerves in regulating motor activities. Given that the neural regulation of movement is a complex and precise network, injury to any component may impair motor function. After ischemic stroke, ischemic injury affects several brain regions involved in movement, leading to various motor impairments. The motor cortex exhibits distinct temporal characteristics following injury. During the acute phase, the main manifestations are muscle weakness, reduced and slowed movement. In the chronic phase, spasticity, clonus, and hypertonia occur due to the weakened inhibition of the cortex on the lower motor centers (Schieber and Poliakov, 1998; Laplane et al., 1977). The basal ganglia inhibits lower motor centers through glutamatergic and dopaminergic inputs, thereby preventing involuntary movements (Grillner et al., 2020), thus its injury primarily leads to contralateral hyperkinetic movement disorders, including dystonia, chorea, and tremor (Park, 2016). Moreover, the white matter tissue near the basal ganglia, the internal capsule, is frequently infarcted after ischemic stroke, leading to severe motor and sensory dysfunction in the contralateral limb (Horie et al., 2019). In contrast, ischemic injury in the cerebellum and brainstem is relatively rare. In over 90% of strokes, the cerebellum and brainstem structures involved in gait control remain intact (Beyaert et al., 2015). Although the spinal cord is not directly damaged after ischemic stroke, it is highly dependent on the regulation from higher centers. After ischemic stroke, the descending inhibitory signals to the spinal cord are weakened due to higher central nervous system injury, which leads to abnormal spinal excitability, increased muscle tone, and spasticity (Urbin et al., 2021; Segal, 2018).
After ischemic stroke, the nervous system initiates a spontaneous repair process to compensate for impaired motor function through limited functional recovery and compensation (Joy and Carmichael, 2021). Neuroplasticity constitutes the pivotal mechanism driving motor recovery after ischemic stroke. Through structural and functional remodeling, it reconstructs and regulates the damaged motor network to adapt to new motor requirements (Alia et al., 2017; Dimyan and Cohen, 2011). Patients often adopt new movement strategies and action patterns to replace pre-stroke movement behaviors, thereby compensating for motor function deficits (Bernhardt et al., 2017). The new motor mode often results in incomplete compensation, reduced precision, and abnormal movement patterns, which may limit motor recovery and even worsen motor impairment (Wahl et al., 2017; Whishaw, 2000). Therefore, timely and effective interventions are crucial. They promote the recovery of impaired function and prevents the spontaneous compensatory process from forming abnormal movement patterns, thereby maximizing overall motor function recovery.
4 Basic studies on acupuncture in promoting motor function recovery after ischemic stroke
Ischemic stroke causes extensive neuronal damage in the early stages, further hindering nerve repair and functional recovery. It disrupts the integrity of the neural network and weakens the regulatory capacity of the motor control system. Acupuncture may exert multidimensional modulation on such pathological changes and neuroplastic processes. It can improve energy metabolism, reduce inflammation, and inhibit apoptosis, thereby reducing neuronal injury and protecting the remaining neurons. Acupuncture also promotes neural plasticity, including enhancing axonal regeneration and synaptic remodeling, and regulating neuronal excitability to optimize the function of the motor circuit. Such roles of acupuncture enable its neuroprotection during the acute phase, while facilitating nerve repair and functional remodeling during the recovery phase, which offers crucial intervention strategies for motor function recovery after ischemic stroke (Table 1).
Table 1
| Authors | Animal model | Acupoint(s) | Acupuncture method | Course of acupuncture | Stroke phase of study | Motor function behavioral testing indicator(s) | Molecular biology indicator(s) |
|---|---|---|---|---|---|---|---|
| Wu et al. (2017) | MCAO rat (I/R) | ST36, LI11 | EA, 2/20 Hz, 30 min/day, once a day | 7 days | Acute phase | MAS, CatWalk XT Gait Analysis, Rota-rod test | Glycolysis rate↑, p-AMPKα/t-AMPKα ratio↑ |
| Lu et al. (2015) | MCAO, rat | PC6, LI11 | EA, 2/15 Hz, 1 mA, 20 min/day, once a day | 7 days | Acute phase | Longa Neurological Score | Lactate concentration↑, MCT1↑ |
| Tian et al. (2022) | MCAO rat (I/R) | GV20, GV26 | EA Pretreatment, 2/50 Hz, 30 min/day, once a day | 5 days | Acute phase | Longa Neurological Score | MMP↑, LC3-II/LC3-I ratio↓, p-ULK1↓, FUNDC1↓ |
| Nie et al. (2024) | MCAO, rat | GV20, ST36 | EA, 2 Hz, 1 mA, 30 min/day, once a day | 14 days | Early subacute phase | Beam-Balance Test | HMGB1↓, JNK↓, p-JNK↓ |
| Liu et al. (2016b) | MCAO rat (I/R) | ST36, LI11 | EA, 1/20 Hz, 4 V, 30 min/day, once a day | 3 days | Acute phase | Longa Neurological Score | NF-κB nuclear translocation↓, NF-κB p65-positive cell count↓ |
| Han et al. (2015) | MCAO, rat | PC6, LI11, SP8 | EA, 2/15 Hz, 1 mA, 30 min/day, once a day | 5 days | Acute phase | Longa Neurological Score | TNF-α↓, IL-1β↓, IL-6↓, TLR4↓, HMGB1↓, TRAF6↓, IKKβ↓, NF-κB p65↓ |
| Lan et al. (2013) | MCAO rat (I/R) | ST36, LI11 | EA, 1/20 Hz | once | Hyper-acute phase | Longa Neurological Score | TLR4↓, NF-κB p65↓, p-IκB↓, NF-κB nuclear translocation↓, TNF-α↓, IL-1β↓, IL-6↓ |
| Zhang et al. (2023a) | MCAO rat, (I/R) | GV14, GV9, GV4, GV20, BL17, BL18, BL23 | MA | 24 h, 36 h, 48 h, 72 h after MCAO(I/R) | Hyper-acute phase, acute phase | Longa Neurological Score | TGF-β↑, TNF-α↓, IL-1β↓, BIRC3 mRNA↓, LTBR mRNA↓, PLCG2 mRNA↓, TLR4 mRNA↓, TRADD mRNA↓ |
| Liu et al. (2016a) | MCAO rat (I/R) | ST36, LI11 | EA, 1/20 Hz, 6 V, 0.2 mA, 30 min/day, once a day | 3 days | Acute phase | mNSS, CatWalk XT Gait Analysis | TNF-α↓, IL-1β↓, IL-6↓, NF-κB nuclear translocation↓, NF-κB p65↓ |
| Ren et al. (2024) | MCAO mice (I/R) | GV20, GV26 | EA, 4/20 Hz, 1 V-3 V, 1 mA–3 mA, 20 min/day, once a day | 3 days | Acute phase | Rotarod Test, neurological deficit score | IL-6↓, TNF-α↓, IL-1β↓, CCL-2↓, CD206↓ |
| Yao et al. (2023) | MCAO rat (I/R) | LU5, LI4, ST36, SP6 | EA, 5 Hz, 2 mA, 20 min/day | 3, 7 days | Acute phase | Longa Neurological Score, Grip Strength Test | STAT6↑, p-STAT6/STAT6 ratio↑, PPARγ↑, p-PPARγ↑, IL-10↑, TGF-β↑, M2 microglia↑, p-NF-κB p65↓, M1 microglia count↓, IL-6↓, TNF-α↓ |
| Wang et al. (2023a) | MCAO rat (I/R) | GV20 | EA, 2/15 Hz, 1 mA, 20 min/day, once a day | 3 days | Acute phase | Longa Neurological Score | IL-10↑, Treg cells↑, TNF-α↓, IL-1β↓, CXCL1 mRNA↓, CXCL2 mRNA↓, IL-17A↓ |
| Zhang et al. (2023b) | MCAO, rat | MS5, MS6 | MA, 30 min/day, once a day | 14 days | Early subacute phase | Longa Neurological Score, Screen-Grabbing Test, Beam-Walking Test | p-IRE1↓, p-PERK↓, ATF6↓, CHOP↓, p-JNK↓, Caspase-3↓, Caspase-9↓ |
| Xing et al. (2018a) | MCAO rat (I/R) | LI11, ST36 | EA, 4/20 Hz, 4 V, 30 min/day, once a day | 3 days | Acute phase | Longa Neurological Score | Bcl-2↑, p-Akt↑, p-PDK1↑, p-GSK-3β↑, Caspase-3↓, Bim↓, p-PTEN↓ |
| Xing et al. (2018b) | MCAO rat (I/R) | LI11, ST36 | EA, 4/20 Hz, 6 V, 1 mA, 30 min/day, once a day | 3 days | Acute phase | Longa Neurological Score | Bcl-2-positive cells↑, Caspase-3-positive cells↓, Bim-positive cells↓, p-ERK1/2↓, p-JNK↓, p-p38↓ |
| Kim et al. (2018) | MCAO mice (I/R) | GV20, GV14 | EA, 2 Hz, 2 V, 20 min/day, once a day | 12 days | Early subacute phase | Corner Test, Cylinder Test | BDNF↑, NT-4↑, VEGF↑, p-TrkB↑, p-CREB↑ |
| Wang et al. (2021a) | MCAO rat (I/R) | GV20, ST36 | EA,100 Hz, 1 mA, 30 min/day, once a day | 14 days | Early subacute phase | Rotarod Test, Beam-Balance Test | BDNF↑, NGF↑, VEGF↑, Nogo-A↓, p75NTR↓ |
| Deng et al. (2016) | MCAO rat (I/R) | GV20 | EA, 2/10 Hz, 1 mA–2 mA, 30 min/day, 5 sessions/week | 7, 14, 21, 28 days | Acute phase, early subacute phase | mNSS, Rotarod Test, Grip Strength Test | BDA-positive CST axon count↑, NF-200↑, GAP-43↑, RhoA↓, PriB↓ |
| Kim et al. (2013) | Photothrombosis stroke (PTS) mice | GV20, GV14 | EA Pretreatment, 2 Hz, 1 mA, 20 min/day, once a day | 3 days | Hyper-acute phase, acute phase | Longa Neurological Score, Wire Hanging Test, Corner Test, Cylinder Test | SDF-1α↑, BDNF↑ |
| Kim et al. (2014) | MCAO rat (I/R) | GV20, GV14 | EA, 2 Hz, 2 V, 20 min/day, once a day | 30 days | Early subacute phase | Rotation Device Test | BDNF↑, VEGF mRNA↑, p-PI3K/BrdU double-positive cell count↑ |
| Xie et al. (2019) | MCAO rat (I/R) | GV20, GV24 | EA, 1/20 Hz, 0.2 mA, 30 min/day, once a day | 14 days | Early subacute phase | Longa Neurological Score | PSD-95 positive cell count↑, SYN positive cell count↑, pyramidal neuron synapse count↑ |
| Ren et al. (2008) | MCAO, rat | PC6, TE5, SP6, ST36 | EA, 10 Hz, 1 mA, 30 min/day, 6 sessions/week | 7, 14, 28 days | Acute phase, early subacute phase | Balance Beam Walking Test | Dendritic spine density↑, Ephrin-A5 mRNA↑ |
| Sun et al. (2022) | MCAO, rat | GB34 | MA, 30 min/day, once a day | 7 days | Early subacute phase | Longa Neurological Score, MAS, Gait Analysis | GABA↑, KCC2↑, GABAAγ2↑ |
| Mu et al., 2022 | MCAO, rat | GB34 | MA, 30 min/day, once a day | 6 days | Early subacute phase | Longa Neurological Score, MAS, Gait Analysis, Foot Balance Test | GABA↑, KCC2↑, GABAAγ2↑ |
| Wang et al. (2021c) | MCAO, rat | GB34 | MA, 30 min/day, once a day | 7 days | Early subacute phase | MAS, Screen Test | KCC2↑, GABAAγ2↑ |
| Wang et al. (2020) | MCAO, rat | GB34 | MA, 30 min/day, once a day | 7 days | Early subacute phase | Longa Neurological Score, MAS | GABA↑, GABA-T↓ |
Characteristic of basic studies.
EA, Electroacupuncture; MA, Manual Acupuncture; ST36, Zusanli; LI11, Quchi; PC6, Neiguan; GV20, Baihui; GV26, Shuigou; SP8, Diji; GV14, Dazhui; GV9, Zhiyang; GV4, Mingmen; BL17, Geshu; BL18, Ganshu; BL23, Shenshu; LU5, Chize; LI4, Hegu; SP6, Sanyinjiao; MS5, Middle line of Vertex in scalp acupuncture; MS6, Anterior Oblique Line of Vertex-Temporal; GV24, Shenting; TE5, Waiguan; MAS, Modified Ashworth Scale; mNSS, Modified Neurological Severity Score.
4.1 Acupuncture reduces nerve damage to improve motor function
4.1.1 Acupuncture regulates energy metabolism
Oxidative metabolism of glucose is the primary energy source for the brain, ensuring the survival and function of neurons (Zheng and Wang, 2018b). In cellular energy regulation, AMP activated protein kinase (AMPK) functions as a crucial energy sensor, detecting changes in cellular energy and regulating abnormal energy states. AMPK can be activated when energy decreases. Subsequently, it increases metabolism-related proteins expression and inhibits biosynthetic pathways to increase ATP (Hardie et al., 2012). After ischemia–reperfusion (I/R) injury, glucose metabolism in the affected hemisphere of rats is significantly lower than in the contralateral hemisphere, and EA can regulate this condition. Additionally, EA enhances energy production and reduces unnecessary energy consumption in brain tissue by activating AMPK, significantly improving gait and athletic ability in rats (Wu et al., 2017). In ischemia and hypoxia following ischemic stroke, due to inhibition of glucose oxidation metabolism, lactate can serve as an alternative energy substrate for neurons (Roumes et al., 2021; Bliss and Sapolsky, 2001). Monocarboxylate Transporter 1 (MCT1), widely distributed in rat brain tissue, promotes the unidirectional transport of monocarboxylates across the plasma membrane, including lactate and pyruvate (Vijay and Morris, 2014). EA upregulates MCT1 expression in astrocytes around the ischemic area and promotes the release of lactate produced by intracellular anaerobic fermentation into the extracellular space, which increases extracellular lactate concentration and provides energy substrates for injured neurons (Lu et al., 2015).
Mitochondria are central to cellular energy metabolism, and their dysfunction is considered a hallmark of I/R injury, making them a critical target for alleviating post-stroke motor impairments (Gibbs et al., 2016). Dysregulation of mitochondrial dynamics and quality control can lead to mitochondrial dysfunction, and even trigger mitochondrial autophagy (Wu et al., 2016). Unc-51-like kinase 1 (ULK1) plays a crucial role in the initial stages of mitochondrial autophagy (Ganley et al., 2009; Wirth et al., 2013). FUN14 domain containing 1 (FUNDC1) acts as a receptor for mitochondrial autophagy under hypoxia and is activated through phosphorylation at the Serine17 site mediated by ULK1. Upon activation, it binds to microtubule-associated protein light chain 3 (LC3) and links mitochondria and autophagosomes, promoting mitochondrial autophagy (Liu et al., 2012; Wu et al., 2014). This process is negatively regulated by the mammalian target of rapamycin (mTOR), a key modulator of cell growth. It prevents ULK1 activation by phosphorylating the Serine-757 site of ULK1, consequently inhibiting ULK1-mediated mitochondrial autophagy (Huang et al., 2011; Kim et al., 2011). EA pretreatment activates mTOR, downregulates p-ULK1, LC3-II/LC3-I, and FUNDC1 levels, which inhibits I/R-induced mitochondrial autophagy and restores mitochondrial membrane potential (MMP). This significantly reduces mitochondrial abnormalities, decreases the number of autolysosomes, which protects neurons from I/R damage and ultimately decreases longa neurological scores (Tian et al., 2022).
4.1.2 Acupuncture alleviates neuroinflammation
After ischemic stroke, severe mitochondrial damage can trigger complex neuroinflammation, which further worsens neuronal injury and significantly impedes motor function recovery. The Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway plays a particularly crucial role in acute inflammation. TLR4 is primarily responsible for recognizing damage-associated or pathogen-associated molecular patterns and initiates immune responses through binding the adaptor protein myeloid differentiation primary response 88 (MyD88) (Barton and Medzhitov, 2003; Stierschneider and Wiesner, 2023). High mobility group box 1 (HMGB1), a key nuclear protein and immune regulatory factor, is released from damaged neurons and glial cells into the extracellular space under ischemia and hypoxia (Wu et al., 2010). I/R injury promotes the rapid binding of HMGB1 to TLR4, which triggers the phosphorylation and degradation of IκB and leads to the migration of the NF-κB subunits (p65/p50) from the cytoplasm to the nucleus. Ultimately, NF-κB activates the transcription of genes related to inflammation and immunity in the nucleus, thereby triggering and aggravating inflammation (Ridder and Schwaninger, 2009; Bhatt and Ghosh, 2014). TNF receptor-associated factor 6 (TRAF6), a downstream factor of TLR4, also participates in regulating the NF-κB pathway (Song et al., 1997). It can phosphorylate IκB by activating IκB Kinase (IKK), thereby promoting the activity of the NF-κB pathway (Wang et al., 2001; Deng et al., 2000). Additionally, TRAF6 further enhances NF-κB activity by activating the c-Jun N-terminal kinase (JNK) signaling pathway, leading to sustained neuroinflammation (Darnay et al., 1999).
EA alleviates inflammation in striatal neurons of rats with cerebral ischemia by downregulating HMGB1, JNK, and p-JNK levels, thereby improving balance and motor coordination (Nie et al., 2024). Additionally, EA inhibits IκB phosphorylation and NF-κB p65 nuclear translocation by reducing TLR4 and its downstream factors, such as TRAF6, IKKβ, tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). This alleviates inflammatory damage in MCAO rats and improves neurological function (Liu et al., 2016b; Han et al., 2015; Lan et al., 2013). Further research shows that EA inhibits the NF-κB pathway by downregulating the key genes expression related to NF-κB, significantly reducing IL-1β and TNF-α levels and increasing tumor necrosis factor-β (TNF-β) levels. Ultimately, EA reduces edema, neuronal damage, and inflammatory infiltration in the ischemic core area caused by I/R and reduces longa neurological scores (Zhang X. et al., 2023).
Microglia are resident immune cells in the central nervous system, playing a key role in regulating immune responses, particularly in central nervous system disorders such as stroke, Parkinson’s disease, and Alzheimer’s disease (Hu et al., 2014; Keren-Shaul et al., 2017). Following activation of the TLR4/NF-κB signaling pathway, microglia rapidly undergo activation and functional polarization. They tend to shift towards the pro-inflammatory M1 phenotype rather than the anti-inflammatory M2 phenotype. Subsequently, a series of pro-inflammatory cytokines are released, further worsening inflammation and expanding neuronal damage (Holtman et al., 2017; Shi et al., 2019). EA significantly inhibits excessive activation and proliferation of microglia in the sensory and motor cortex surrounding the infarction and prevents their polarization towards the M1 type, which reduces the expression of TNF-α, IL-1β, and IL-6 in both the cortex and serum. This alleviates I/R-induced neuroinflammation and improves motor coordination, balance, and gait in rats (Liu et al., 2016a; Ren et al., 2024). The Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway is a critical intracellular signaling pathway that binds to cytokines, hormones, and other molecules through receptors on the cell surface, transmits signals to the nucleus, and regulates gene transcription (Xin et al., 2020; Renauld, 2003). In the later stages of inflammation, anti-inflammatory factors such as interleukin-4 (IL-4) and interleukin-13 (IL-13) activate JAK1, which in turn activates STAT6. Together with peroxisome proliferator-activated receptor γ (PPARγ), they promote microglia polarization towards the M2 type, ultimately fostering an anti-inflammatory response and tissue repair (He Y. et al., 2020a). EA increases the total expression of STAT6 and PPARγ in microglia and promotes their activation, thereby facilitating the polarization of M1 microglia towards M2 and regulating the levels of corresponding pro-inflammatory and anti-inflammatory factors. This reduces longa neurological scores and improves muscle strength in the hind limbs of rats (Yao et al., 2023).
Th17 cells primarily participate in immune responses by secreting pro-inflammatory factors such as interleukin-17 (IL-17), interleukin-21 (IL-21) and interleukin-22 (IL-22) (Stockinger and Veldhoen, 2007). Treg cells primarily prevent excessive immune responses and autoimmune diseases by secreting immunosuppressive factors, such as transforming growth factor-beta (TGF-β) and interleukin-10 (IL-10). Under normal conditions, they inhibit overactive T helper 17 (Th17) cells and maintain immune tolerance and an anti-inflammatory response (Afzali et al., 2007; Liesz et al., 2009). The balance between Th17 cells and Treg cells is crucial in regulating neuroinflammation and restoring exercise capacity after stroke (Liu et al., 2015; Dolati et al., 2018). C-X-C motif chemokine ligand 1 (CXCL1) and C-X-C motif chemokine ligand 2 (CXCL2) are important inflammatory chemokines that promote Th17 cells differentiation and exacerbate neuroinflammation in combination with pro-inflammatory factors (Wojkowska et al., 2014). EA promotes the differentiation of Treg cells and IL-10 secretion in brain tissue, while downregulating the gene expression of CXCL1 and CXCL2, as well as the levels of interleukin-17A (IL-17A), TNF-α, and IL-1β. This ultimately reduces neuroinflammation and reduces longa neurological scores (Wang et al., 2023a, 2023b).
4.1.3 Acupuncture inhibits cell apoptosis
Caspase-mediated apoptosis plays a critical role in neuronal death after ischemic stroke (Love, 2003). Caspases are a class of cysteine proteases, including both initiator and executioner types, that play a central role in cell apoptosis. Pro-apoptotic factors regulate caspase activation along with the anti-apoptotic factor B-cell lymphoma 2 (Bcl-2), such as Bcl-2 interacting mediator of cell death (Bim), Bcl-2 antagonist of cell death (Bad), and Bcl-2 associated x protein (Bax). Mitochondria damaged by ischemic stroke release cytochrome c, which binds to the apoptotic protease activating factor 1 (Apaf-1) and procaspase-9, forming apoptotic bodies and initiating a series of apoptotic events (Zhang and Armstrong, 2007; Love, 2003). Executioner caspases, primarily caspase-3, complete the final stages of apoptosis by degrading the genome and breaking down the cytoskeleton (Unnisa et al., 2023).
The endoplasmic reticulum (ER) is the primary organelle responsible for protein synthesis, transport, and the maintenance of intracellular Calcium ion (Ca2+) homeostasis. The imbalance in Ca2+ homeostasis caused by cerebral ischemia leads to the unfolded protein response (UPR) and accumulation, which in turn induces ER stress and initiates apoptosis (Han et al., 2021; Marciniak and Ron, 2006; Walter and Ron, 2011). Studies have shown that ER stress induced by cerebral ischemia is a key pathological mechanism related to damage to neurons, glial cells, and endothelial cells (Rissanen et al., 2006; Zhao et al., 2018; Haupt et al., 2020). Targeted inhibition of ER stress and the UPR can effectively alleviate experimental I/R injury (Zhao et al., 2018; Liu et al., 2020). The UPR, activated by ER stress, activates the expression of downstream pro-apoptotic factors by core sensors including inositol-requiring enzyme 1 (IRE1), protein kinase r -like endoplasmic reticulum kinase (PERK), and activating transcription factor 6 (ATF6) (Walter et al., 2018). Acupuncture reverses ischemia-induced ER swelling by downregulating the expression of p-IRE1, p-PERK, and ATF6. This inhibits the activity of pro-apoptotic factors such as JNK and C/EBP-homologous protein (CHOP), and downregulates the levels of caspase-9 and caspase-3, thereby inhibiting apoptosis of cortical penumbra neurons induced by ER stress and alleviating paralysis or spasticity after ischemic stroke (Zhang Y. et al., 2023).
The mitogen-activated protein kinase (MAPK) pathway is a crucial regulator of cell differentiation, inflammation, and apoptosis. It consists mainly of three functional branches: the extracellular signal-regulated kinase (ERK) pathway, JNK pathway, and p38 pathway. The dynamic balance between these pathways is crucial for determining cell survival or apoptosis (Xia et al., 1995; Peti and Page, 2013). Studies show that ERK1/2 is overexpressed in MCAO animals, and inhibiting ERK1/2 phosphorylation can reduce focal infarct volume and brain damage and provide neuroprotection (Zhang et al., 2010; Wang et al., 2003; Namura et al., 2001). JNK and p38 are important therapeutic targets in ischemic stroke, as they promote inflammatory responses, induce neuronal apoptosis, and exacerbate ischemic damage (Gao et al., 2005; Zheng et al., 2018a; Jiang et al., 2014; Barone et al., 2001). EA restores the balance of the ERK/JNK/p38 pathway by downregulating the activation of ERK1/2, JNK, and p38 in cortical infarcted areas. This promotes Bcl-2 expression and downregulates the levels of caspase-3 and Bim ultimately reducing longa neurological scores (Xing et al., 2018b).
Protein kinase B (Akt) is a key molecule that inhibits neuronal apoptosis (Vidal et al., 2022; Zheng et al., 2024; Liu et al., 2025). Phosphatidylinositol 3-kinase (PI3K) can induce the phosphorylation and activation of Akt. After activation, it recruits Akt and 3-phosphoinositide-dependent kinase 1 (PDK1) to the membrane by promoting the conversion of phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3) (Alessi et al., 1996; Stokoe et al., 1997). PDK1 phosphorylates the Threonine 308 site of Akt, enabling it to regulate the activity of various substrates such as glycogen synthase kinase 3 beta (GSK3β), Bad, and Bim, thus playing an anti-apoptotic role (Vidal et al., 2022; Kaidanovich-Beilin and Woodgett, 2011; Datta et al., 1997; Qi et al., 2006). The phosphatase and tensin homolog (PTEN) located on chromosome 10 dephosphorylates the Threonine 308 site of Akt by catalyzing the conversion of PIP3 to PIP2, thereby inhibiting the anti-apoptotic effect of Akt (Maehama and Dixon, 1998; Li et al., 1997; Lee et al., 2004). EA upregulates the phosphorylation levels of PDK1, Akt, and GSK-3β in the cortex surrounding the infarction, inhibits PTEN expression, significantly reduces caspase-3 and Bim, and reverses the decrease in Bcl-2 induced by ischemia. This significantly reduces infarct volume and decreases the proportion of apoptotic cells, so as to reduce longa neurological scores in rats with cerebral ischemia (Xing et al., 2018a).
Taken together, the major mechanisms involved in the efficacy of acupuncture in promoting motor function following ischemic stroke via improving energy metabolism, reducing neuroinflammation, and inhibiting cell apoptosis, are shown in Figure 1.
Figure 1
4.2 Acupuncture restructures neural circuits to improve motor function
4.2.1 Acupuncture facilitates nerve repair and regeneration
Neurotrophic factors, including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 (NT3), and neurotrophin 4 (NT4), participate in the development of the nervous system and the repair process following nerve injury by binding to specific receptors. BDNF and NT4 activate cAMP response element-binding protein (CREB) by binding to tropomyosin receptor kinase B (TrkB), upregulating genes related to nerve repair and growth, and promoting neuronal repair. NGF primarily exerts its neurotrophic effect by binding to tropomyosin receptor kinase A (TrkA) (Bai et al., 2019). Vascular endothelial growth factor (VEGF) is a key growth factor responsible for the generation and expansion of blood vessels. It provides neuroprotection and promotes nerve regeneration by inducing angiogenesis (Plate et al., 1999; Böcker-Meffert et al., 2002). EA increases the expression of BDNF, NT4, and VEGF, promotes the activation of TrkB and CREB, facilitates NSCs proliferation and differentiation, thereby alleviating striatal atrophy in MCAO/R mice and restores bilateral paw motor function. Its effect is stronger than that of mouse bone mesenchymal stem cells transplantation, particularly in terms of motor function related to ipsilateral turning (Kim et al., 2018).
After activation of the corresponding signaling pathways by neurotrophic factors, cytoskeletal remodeling is initiated, and the direction of axonal growth is guided by microtubules and microfilaments, thereby promoting the reconstruction of neural networks (Markus et al., 2002; Chen et al., 2017). Neurite outgrowth inhibitor A (Nogo-A) binds to the Nogo-66 receptor 1 (NgR1) and releases Ras homolog gene family member A (RhoA) in combination with the p75 neurotrophin receptor (p75NTR) (Schwab and Strittmatter, 2014). RhoA further activates Rho kinase (ROCK), in turn leading to actin cytoskeleton recombination, resulting in cone collapse and inhibition of neurite outgrowth (Fan et al., 2016). EA combined with constraint-induced exercise upregulates the levels of NGF, VEGF, and BDNF and inhibits the expression of Nogo-A and p75NTR, which significantly improves movement balance in MCAO/R rats (Wang D. et al., 2021). Growth-associated protein 43 (GAP-43) and neurofilament 200 (NF-200) promote axonal regeneration and synaptic plasticity, while paired immunoglobulin-like receptor B (PirB) inhibits neuronal burst growth by activating RhoA, thereby suppressing motor function recovery after ischemic stroke (Deng et al., 2018). EA upregulates the expression of NF-200 and GAP-43, while inhibiting PirB and RhoA expression to relieve the inhibition of axonal regeneration, which effectively repairs the motor pathway between the brain and spinal cord, ultimately enhancing muscle strength and promoting motor function recovery in rats (Deng et al., 2016). Postsynaptic density protein 95 (PSD-95) and synapsin (SYN) are critical proteins in synapses, playing a key role in regulating synaptic strength and activity-dependent synaptic plasticity (Béïque and Andrade, 2003; Tarsa and Goda, 2002). EA improves the decreased number and ultrastructure of synapses after I/R injury by increasing the number of PSD-95-positive and SYN-positive cells, thereby promoting neural plasticity in the brain (Xie et al., 2019). Ephrin-A5 participates in synapse formation and maturation by binding to EphA receptors (Otal et al., 2006). EA upregulates ephrin-A5 expression, increases the density and length of dendritic spines in the infarcted cortical area, thereby promoting functional recovery following ischemic stroke (Ren et al., 2008).
NSCs, as the primary source of neuronal regeneration, promote neural repair and motor function recovery by proliferating, differentiating, and migrating to generate new neurons, astrocytes, and oligodendrocytes (Tang et al., 2017). Stromal cell-derived factor 1 alpha (SDF-1α) promotes neural regeneration and behavioral recovery after ischemic stroke by enhancing the recruitment of endogenous NSCs (Luo et al., 2014; Deng et al., 2021; Zhao et al., 2015). Three days of EA pretreatment increase BDNF levels in the brain tissue of photothrombosis stroke mice and upregulates SDF-1α in plasma, significantly improving vestibular motor function, sensory motor function and forelimb symmetry (Kim et al., 2013). EA also increases the number of newly formed NSCs in the hippocampus, promotes their differentiation into neurons or astrocytes, and upregulates the levels of BDNF and VEGF (Kim et al., 2014).
4.2.2 Acupuncture regulates neuronal excitability
Neuronal excitability refers to the ability of neurons to respond to stimuli and generate action potentials, directly affecting the normal function and stability of neural circuits (Turrigiano, 2011). After ischemic stroke, the connections between different regions of the nervous system related to movement are severely disrupted, causing an imbalance in neuronal excitability and motor impairments (Li et al., 2019; Hubli et al., 2012). Glutamate (Glu), the primary excitatory neurotransmitter in the central nervous system, maintains normal neuronal excitability by mediating the influx of Ca2+ (Hansen et al., 2021). Under pathological conditions, abnormal accumulation of excitatory amino acids in synaptic gaps can cause sustained neuronal overexcitation, leading to synaptic transmission disorders and Ca2+ overload. This disrupts neural network homeostasis and damages neural circuits related to motor control. Research shows that after ischemic stroke, impaired high-level central regulatory function leads motor neurons to frequently send abnormal nerve impulses, causing sustained muscle spasms and worsening motor impairments and disabilities (Trompetto et al., 2019). Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, produced by the decarboxylation of Glu catalyzed by glutamate decarboxylase 67 (GAD67) and degraded by GABA-transaminase (GABA-T) (Lee et al., 2019). GABA inhibits neuronal excitability through two distinct pathways. Firstly, it diminished the excitatory signals of glutamatergic neurons and inhibits Glu release via presynaptic inhibition. Secondly, through postsynaptic inhibition, it binds to GABA receptors to promote Chloride ion (Cl−) influx, which subsequently leads to neuronal membrane hyperpolarization and a reduction in neuronal excitability (Chalifoux and Carter, 2010; Kaila, 1994; Li et al., 2002). The Potassium-Chloride co-transporter 2 (KCC2), located on the neuronal cell membrane, maintains low intracellular Cl− levels by expelling Cl−, thereby facilitating GABA-mediated Cl− influx and effectively inhibiting excessive excitability in motor neurons (Rivera et al., 2005; Watanabe et al., 2009). Several studies show that acupuncture upregulates GABA levels, enhances the expression of KCC2 and GABAA, and inhibits GABA-T activity in the nervous system of MCAO rats, thereby restoring normal neuronal excitability and promoting functional recovery of spastic limbs after ischemic stroke (Sun et al., 2022; Mu et al., 2022; Wang J. X. et al., 2021; Wang et al., 2020).
The major mechanisms involved in the efficacy of acupuncture in improving motor function after ischemic stroke via facilitating nerve repair and regeneration and regulating neuronal excitability are shown in Figure 2.
Figure 2
5 Clinical studies on acupuncture in promoting motor function recovery after ischemic stroke
5.1 Outcome measures of acupuncture effects
Currently, several methods are used in clinical practice to comprehensively evaluate the efficacy of acupuncture in promoting post-stroke motor function recovery. The Fugl-Meyer Assessment (FMA) is the most commonly used scale for evaluating motor function, widely employed to objectively quantify motor, sensory, and joint function impairment in stroke patients (Fugl-Meyer et al., 1975). Nine studies used FMA to assess motor recovery in post-stroke patients (Wang et al., 2023a; Wayne et al., 2005; Xie et al., 2022; Tian et al., 2016; Gao et al., 2012; Xiong et al., 2020; Zhan et al., 2023; Bai et al., 2013; Wang et al., 2025). Motor and sensory impairment after ischemic stroke severely affects patients’ ability to perform daily activities. Therefore, the Barthel Index (BI) is often used to assess the ability to perform activities of daily living. It evaluates patients’ independence in basic daily activities, such as eating, dressing, and walking, and is used for rehabilitation assessment in stroke, Alzheimer’s disease, and spinal cord injury (Sulter et al., 1999). Eight studies utilized BI to evaluate functional independence in post-stroke patients (Wayne et al., 2005; Xie et al., 2022; Tian et al., 2016; Gao et al., 2012; Duc Nguyen et al., 2023; Zhan et al., 2023; Bai et al., 2013; Wang et al., 2025). The combined use of the FMA and BI comprehensively and dynamically evaluates the recovery status of patients.
Despite these scales are rich in content and convenient to use, they still have certain limitations. Scoring relies on the evaluator’s experience, introducing subjective bias, while limited sensitivity may reduce their effectiveness in detecting mild motor impairments. Combining subjective scales with objective indicators improves the accuracy and objectivity of evaluations. It provides a more comprehensive and accurate reflection of the effect of acupuncture on motor function recovery after ischemic stroke. Electromyography (EMG) effectively reveals weakened muscle strength, abnormal muscle tone, and motor control disorders caused by central nervous system injury in stroke patients by recording muscle electrophysiological activity. Two studies use EMG to evaluate muscle function after acupuncture (Duc Nguyen et al., 2023; Wang et al., 2025). Functional magnetic resonance imaging (fMRI) is a key technique for revealing the functional reorganization of the central nervous system after stroke. Three studies use fMRI to evaluate the effects of acupuncture on brain functional networks (Wang et al., 2023b; Schaechter et al., 2007; Zhan et al., 2023). They revealed the strength of brain network functional reorganization and spontaneous neural activity by analyzing functional connectivity and low-frequency amplitude. These imaging results reflect the activity and recovery of motor-related brain areas, highlighting the potential of acupuncture in promoting brain functional reorganization and enhancing neural plasticity. The use of other evaluation indicators is shown in Table 2.
Table 2
| Authors | Sample size | Acupuncture method | Course of acupuncture | Stroke phase of study | Outcome(s) |
|---|---|---|---|---|---|
| Wang et al. (2023b) | 53 | MA, 30 min/day, 5 sessions/week | 2 weeks | Early subacute phase | FMA↑, fMRI |
| Wayne et al. (2005) | 33 | EA, 60 min/day, 2 sessions/week | 10 weeks | Chronic phase | MAS↓, ROM↑, FMA↑, BI↑ |
| Xie et al. (2022) | 90 | MA, 30 min/day, 5 sessions/week | 4 weeks | Late subacute phase | FMA↑, BI↑, MMT↑ |
| Tian et al. (2016) | 68 | EA, 5/20 Hz, 30 V, 1 mA–2 mA, 30 min/day, 6 sessions/week | 2 weeks | Early subacute phase | NIHSS↓, FMA↑, BI↑ |
| Gao et al. (2012) | 106 | MA, 45 min/day, once a day | 4 weeks | Subacute phase | FMA↑, BI↑, NDS↓ |
| Xiong et al. (2020) | 72 | MA, 3–4 h/day, 6 sessions/week | 8 weeks | Late subacute phase | FMA↑, MMSE↑, LOTCA↑, ADL↓ |
| Zhan et al. (2023) | 108 | MA. 30 min/day, 5 sessions/week | 8 weeks | Subacute phase | FMA↑, BI↑, mRS↑, fMRI |
| Bai et al. (2013) | 120 | MA, 30 min/day, 6 sessions/week | 4 weeks | Early subacute phase | FMA↑, BI↑ |
| Wang et al. (2025) | 90 | TEAS, 20 Hz, 100 Hz, 30 min/day, 3 sessions/week | 4 weeks | Late subacute phase, chronic phase | FMA↑, MAS↓, BI↑, EMG |
| Duc Nguyen et al. (2023) | 120 | EA, 50 Hz–100 Hz, 30 min/day, 5 sessions/week | 6 weeks | Subacute phase | BI↑, MSG↑, mRS↓, EMG |
| Schaechter et al. (2007) | 7 | EA, 2 sessions/week | 10 weeks | Chronic phase | fMRI |
Characteristic of clinical studies.
EA, Electroacupuncture; MA, Manual Acupuncture; TEAS, Transcutaneous Electrical Acupuncture Stimulation; ROM, Range of Motion; MMT, Manual Muscle Testing Scale; NIHSS, National Institutes of Health Stroke Scale; NDS, Neurological Deficit Score; MMSE, Mini-Mental State Examination; LOTCA, Loewenstein Occupational Therapy Cognitive Assessment; ADL, Activity of Daily Living; MSG, Muscle Strength Grading, mRS: Modified Rankin Scale.
5.2 Acupuncture intervention modalities
5.2.1 Stimulation sites
It is a feature of acupuncture that appropriate acupoints are selected based on individual’s symptoms and syndromes (a series of clinical manifestations reflecting the pathogenesis of a disease). The choice of stimulation sites is an important factor affecting the efficacy of acupuncture. Considering that basic studies primarily focus on exploring the mechanisms of acupuncture, to optimize experimental controllability and reproducibility, a limited number of acupoints and simplified acupuncture techniques are typically used. The two most commonly used acupoints are GV20 and ST36. However, clinical studies place more emphasis on individualized treatments to achieve better effects, therefore, more acupoints are usually applied, such as GB34, LI4, GV20, LI15, LI11, SP6, and TE5. The appearance frequency of most commonly-used acupoints is shown in Table 3 and Figure 3.
Table 3
| Basic experiments | Frequency (times) | Clinical trials | Frequency (times) |
|---|---|---|---|
| GV20-Baihui | 10 | GB34-Yanglingquan | 7 |
| ST36-Zusanli | 9 | LI4-Hegu | 7 |
| LI11-Quchi | 8 | TE5-Waiguan | 4 |
| GB34-Yanglingquan | 4 | LI15-Jianyu | 4 |
| GV26-Shuigou | 3 | LI11-Quchi | 4 |
| GV14-Dazhui | 3 | SP6-Sanyinjiao | 3 |
| PC6-Neiguan | 2 | GV20-Baihui | 3 |
| GB20-Fengchi | 3 | ||
| GB31-Fengshi | 3 | ||
| GB30-Huantiao | 3 | ||
| PC6-Neiguan | 3 | ||
| LI10-Shousanli | 3 | ||
| ST36-Zusanli | 3 |
Utilization frequency of commonly used acupoints.
Figure 3
Conventional treatment typically targets the affected limb to facilitate motor function restoration. Nonetheless, acupuncture applied to the healthy limb also confers significant therapeutic benefits. Research shows that activity in the healthy hemisphere is increased during the first 10 days after stroke, followed by a gradual increase in activity in the impaired hemisphere. This dynamic neural activation process is closely linked to the recovery of motor function (Marshall et al., 2000; Ward et al., 2003). When the lesion affects most of the motor-related areas, the role of the healthy hemisphere in functional reorganization and motor recovery is especially critical (Di Pino et al., 2014). One study compares the therapeutic effects of acupuncture on the healthy and affected sides. The results show that under the same acupoint selection, needling on the healthy limb has a more significant effect on improving FMA and BI scores, and reducing neurological deficit score (NDS) (Gao et al., 2012). This suggests that acupuncture on the healthy limb may promote overall motor function recovery by regulating the function of the healthy hemisphere. Its underlying mechanism requires further exploration.
5.2.2 Stimulation methods
Existing research and classical theories suggest that different acupuncture techniques can significantly influence treatment efficacy (Davis et al., 2012; Wang J. et al., 2021). Compared to manual acupuncture, EA provides stable and continuous stimulation and accurately activates specific acupoints by adjusting pulse width, intensity, and frequency (Zhang et al., 2022). A study showed that EA is more effective than manual acupuncture in reducing National Institutes of Health Stroke Scale (NIHSS) scores and improving FMA and BI scores (Tian et al., 2016). Additionally, transcutaneous electrical acupuncture stimulation (TEAS) stimulates acupoints directly through the skin by attaching electrode pads. Combining TEAS, particularly in 100 Hz, with routine care significantly improves FMA and BI scores, increases limb co-contraction rates, and reduces MAS score and spastic muscle activity levels in patients with post-stroke spastic hemiplegia (Wang et al., 2025). Fire needle therapy is a method of rapidly penetrating the acupoint with a red burning needle tip to treat diseases. A meta-analysis indicates that fire needle performs better in reducing MAS than manual acupuncture especially in the upper limbs. In other scales, such as FMA, BI, and NDS, fire needle also shows a more significant effect (Qiu et al., 2021). By the way, warm needle acupuncture, which combines acupuncture and moxibustion, can deeply stimulate acupoints and enhance efficacy by transmitting warmth from burning moxa wool through the needle. A network meta-analysis compares the efficacy of various acupuncture techniques and finds that warm needle acupuncture is more effective in relieving spasticity in elderly stroke survivors, while manual acupuncture was more beneficial in improving overall motor function (Zhu G. C. et al., 2024). This suggests that the personalized selection of acupuncture techniques based on specific conditions is an effective strategy for improving clinical efficacy.
5.2.3 Intervention time
The Stroke Recovery and Rehabilitation Roundtable (SRRR) classifies acute cerebral ischemia into five phases: hyperacute (within 24 h), acute (1–7 days), early subacute (7 days to 3 months), late subacute (3–6 months), and chronic (over 6 months) (Bernhardt et al., 2017). Most stroke survivors undergo spontaneous functional recovery in the early stages, but the duration varies depending on the affected neurological system (Cramer et al., 2007). For example, motor function typically improves within weeks to months after stroke, while language function recovery may take months to years (Nakayama et al., 1994). The first week to the first month after stroke is a critical period for neural plasticity, making this stage a key focus for rehabilitation therapy and clinical studies (Krakauer et al., 2012; Biernaskie et al., 2004). Although the optimal time window for acupuncture intervention remains undetermined, existing evidence indicates that earlier initiation and increased treatment frequency improve motor function and alleviate inflammatory responses (Wu et al., 2023; Xu et al., 2020). This may be linked to the mechanism of acupuncture that alleviates nerve damage during the acute phase of stroke by improving energy metabolism, regulating inflammation, and inhibiting cell apoptosis. A meta-analysis shows that early acupuncture intervention, particularly within 48 h after stroke, significantly improves FMA and BI scores, with efficacy lasting up to 15 days after onset, significantly better than late intervention (Zhuo et al., 2021). Nevertheless, current clinical studies primarily focus on the subacute and chronic phases, with relatively limited studies on the acute phase. Greater emphasis on early-stage acupuncture in future studies may help refine intervention timing and improve the efficacy of motor function recovery.
5.2.4 Combined therapies
In clinical rehabilitation after ischemic stroke, a comprehensive intervention incorporating multiple treatment methods is commonly employed. Acupuncture can significantly enhance the effectiveness of motor function recovery when combined with conventional rehabilitation training, medication therapy, and other techniques. Several meta-analyses show that combining conventional rehabilitation, medication therapy, and mirror training with acupuncture further enhances motor function and accelerates the rehabilitation process (Cai et al., 2017; Lv et al., 2021; Peng et al., 2024; Tao et al., 2023; Zhan et al., 2018; Zhang et al., 2024; Zhu T. et al., 2024). Additionally, compared to using EA alone, a comprehensive plan that combines conventional rehabilitation therapy demonstrates superior performance in modulating the electromyographic frequency and amplitude in post-stroke patients with motor impairments. It also effectively enhances motor function and daily living ability (Duc Nguyen et al., 2023). These findings suggest that acupuncture, as an effective complementary therapy, is more beneficial when combined with conventional rehabilitation treatment than when used alone. In clinical practice, the cooperative effects of multiple intervention methods can optimize motor function recovery and significantly improve the quality of life. Current studies directly comparing the efficacy of acupuncture and conventional rehabilitation therapy remain limited. Future high-quality research evaluating their independent effects is needed to clarify the respective advantages of each approach and provide stronger evidence to support therapeutic strategies.
6 Challenges and recommendations for future studies
6.1 Advancements and limitations in basic studies
The exploration of the mechanisms by which acupuncture promotes motor function recovery following ischemic stroke offers a scientific foundation for its clinical application, and is of paramount importance for understanding such a traditional therapy and facilitating its wider clinical adoption in post-stroke rehabilitation. Acupuncture exerts neuroprotective and reparative effects through multiple pathways and targets, facilitating motor function recovery. During the acute injury phase after ischemia, acupuncture restores energy balance in neural tissue by promoting glycolysis and lactate metabolism, reducing mitochondrial damage, and regulating mitophagy. Neuroinflammation plays a critical role in early nerve damage and long-term motor dysfunction. Acupuncture effectively inhibits inflammation and promotes neuroprotection by suppressing excessive activation of the TLR4/NF-κB signaling pathway, balancing microglial polarization, and restoring the Th17/Treg cell balance. It also inhibits neuronal apoptosis by regulating ER stress, the MAPK pathway, and the PI3K/Akt pathway. During the neural repair phase, acupuncture repairs damaged neural network structures by upregulating neurotrophic factors, promoting axonal growth and synaptic plasticity, and regulating the proliferation and differentiation of NSCs. Besides, acupuncture regulates neuronal excitability to ensure normal transmission of neural signals, providing the necessary foundation for the recovery of neural function. In summary, acupuncture provides neuroprotection by reducing ischemia-induced nerve damage in the early stages of ischemic stroke and promotes the reconstruction of the nervous system and repair of neural circuits in later stages, facilitating comprehensive motor function recovery across multiple stages.
Currently, basic studies on acupuncture mainly focus on regulating specific signaling pathways or repairing ischemic areas. However, the overall remodeling of neural networks, especially the repair of complex motor neural circuits after ischemic stroke, is critical in determining motor function recovery (George and Steinberg, 2015). The mechanism of acupuncture is multi-level and multi-dimensional, offering unique advantages in promoting the overall recovery of neural network structure and function, although many of its underlying mechanisms remain unexplored. Recent research has shown that using projection-specific and mononuclear RNA sequencing techniques to identify characteristic neurons associated with movement and observe their directed regeneration to natural target areas is essential for motor function recovery (Squair et al., 2023). Therefore, using modern technologies such as gene silencing or knockout, virus tracing, optogenetics, chemical genetics, small animal functional magnetic resonance imaging, two-photon microscopy, and combining single-cell sequencing and spatial transcriptomics, to deeply observe the repair and activity of neural circuits and explore how acupuncture promotes the functional reconstruction of motor-related brain regions and specific neural circuits has become a new research trend.
6.2 Suggestion for optimizing clinical studies
In addition to basic studies, clinical studies in this field may provide optimized acupuncture approaches for post-stroke motor dysfunction. Research indicates that at different stages of motor recovery, patients’ rehabilitation needs for neural functions vary. The effectiveness of acupuncture largely depends on the selection of stimulation sites and techniques (Stinear, 2010). Therefore, targeted acupuncture treatment should be used at the different stages of recovery to maximize rehabilitation effectiveness, which warrants further investigation. The optimal timing for acupuncture intervention remains unclear. However, multiple studies indicate that early intervention is critical for functional recovery after ischemic stroke, and early acupuncture treatment can significantly enhance motor function recovery (Coleman et al., 2017; Lou et al., 2024). Given that acupuncture can effectively inhibit nerve damage during the acute phase, initiating acupuncture treatment as early as possible may help promote motor function recovery. Furthermore, basic studies show that EA pretreatment can regulate mitochondrial autophagy, promote NSC proliferation and differentiation, thereby exerting neuroprotective and reparative effects, and improving motor function (Kim et al., 2013; Tian et al., 2022). This suggests that acupuncture both alleviates injuries after ischemic stroke and enhances the body’s tolerance to such injuries, indicating its potential preventive effects. Despite this, the clinical research and application of acupuncture pretreatment remain limited. Future research should explore the mechanisms and clinical effects of acupuncture pretreatment, and develop corresponding acupuncture pretreatment protocols for high-risk stroke populations.
Acupuncture has become an ideal choice for promoting motor function recovery when combined with other therapies, due to its non-invasive nature, simplicity, and good patient compliance. Combining acupuncture with medication, exercise rehabilitation, and other treatment methods can significantly enhance clinical efficacy. Currently, innovative technologies such as stem cell transplantation, brain-computer interfaces, robotic assistance, and non-invasive brain stimulation have been used to promote post-stroke motor function recovery but have not yet been integrated with acupuncture research (Raffin and Hummel, 2018; Soekadar et al., 2015; Muir et al., 2020; McCrary et al., 2020). Future research should investigate the combined effects of these innovative therapies and acupuncture, expand the application scenarios of acupuncture, and provide new strategies for improving motor function after ischemic stroke in clinical practice.
Although current clinical studies have demonstrated the positive effects of acupuncture in promoting motor function recovery, several methodological issues remain noteworthy. First, due to the inherent characteristics of acupuncture interventions, implementing conventional blinding methods presents certain challenges, which may affect the objectivity of study outcomes. Second, some studies included small sample sizes, resulting in insufficient statistical power and limited generalizability of the findings. In addition, many clinical studies lack standardized acupuncture protocols, with insufficiently detailed descriptions of intervention parameters. Future research should focus on designing more scientifically rigorous randomized controlled trials with appropriately calculated sample sizes. Moreover, it is recommended that researchers adhere strictly to the CONSORT statement and the STRICTA guidelines to ensure transparent and systematic reporting of both intervention details and study outcomes. These improvements will contribute to a more robust evidence base for the clinical application of acupuncture in motor function recovery following ischemic stroke.
6.3 Challenges from basic to clinical studies
Although basic studies have identified many potential targets and effective pathways in treatment and have reported significant therapeutic effects, they still face multiple challenges when translating research results to clinical practice due to differences between basic and clinical studies.
Firstly, experimental ischemic stroke is primarily modeled by creating permanent ischemia or reperfusion through the suture method, which simulates blood flow obstruction and reperfusion in a simplified manner. As this method cannot fully replicate the complex pathological features of non-experimental ischemic stroke, the generalizability of experimental findings remains limited.
Secondly, most studies use young and healthy animals, as their physiological conditions are more standardized, facilitating experimental consistency. Their strong recovery ability allows researchers to observe a more complete recovery process within a shorter period. In clinic, ischemic stroke predominantly affects middle-aged and elderly individuals, who are often accompanied by chronic conditions such as hypertension and diabetes. These factors significantly influence both the occurrence and functional recovery of ischemic stroke (Lou et al., 2024; Luitse et al., 2012). Therefore, using young animals for research does not fully reflect the pathological characteristics of high-risk stroke populations.
Furthermore, basic studies often use simplified acupuncture protocols to ensure standardization, which differs significantly from clinical acupuncture protocols. To a certain degree, basic studies should gradually align with clinical acupuncture protocols based on animal characteristics to enhance their feasibility for clinical translation. Moreover, existing basic studies primarily focus on cortical ischemic areas, with less emphasis on the more common subcortical ischemic injuries, including the internal capsule, seen in clinical practice (Corbetta et al., 2015). This may be due to the internal capsule being located deep in the brain, with relatively low white matter content in rodent brains, which makes it a significant technical challenge to induce precise lesions in this area (Blasi et al., 2015). Simultaneously, the neural circuits involved are more complex, and research needs to consider the synergistic effects across multiple brain regions, requiring more sophisticated techniques and evaluation methods. This difference may result in incomplete research on the mechanisms of acupuncture, preventing a full research of its comprehensive effects on motor-related brain regions.
In conclusion, the discrepancies between basic and clinical studies may affect the consistency of findings. Future efforts should focus on bridging the two to enhance the clinical translatability of acupuncture mechanism studies.
7 Conclusion
In conclusion, this review comprehensively evaluates the mechanisms and clinical characteristics of acupuncture in promoting motor function recovery after ischemic stroke, based on a large body of basic and clinical studies, emphasizing its overall role in functional recovery. We have demonstrated that acupuncture repairs neural structures and reshapes motor function through multiple pathways at various stages of the disease, including restoring energy metabolism, inhibiting neuroinflammation, preventing neuronal apoptosis, promoting neuronal repair and regeneration, and regulating neuronal excitability. Additionally, we explored the key role of different acupuncture protocols in improving motor function and emphasized the necessity of personalized treatment and protocol optimization. Through a deep analysis of these studies, this review provides theoretical support for the application of acupuncture in post-stroke motor function recovery and offers new insights and directions for future research. Further exploration of acupuncture’s potential in motor function repair through modern technologies will expand its application in stroke rehabilitation, providing more practical guidance for clinical treatment.
Statements
Author contributions
J-LH: Formal analysis, Writing – original draft, Data curation, Writing – review & editing, Conceptualization. L-XM: Resources, Writing – review & editing, Project administration, Funding acquisition. J-SW: Investigation, Software, Methodology, Writing – review & editing. Y-XZ: Investigation, Methodology, Software, Writing – review & editing. XQ: Validation, Visualization, Writing – review & editing. L-HM: Writing – review & editing, Supervision. J-YX: Visualization, Validation, Writing – review & editing. X-YW: Validation, Writing – review & editing, Visualization. M-YC: Visualization, Validation, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by the National Natural Science Foundation of China, grant no. 82274655.
Acknowledgments
We would like to thank the scientific illustration software BioRender (www.biorender.com) for creating the illustrations.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
- NSC
Neural stem cell
- dMSNs
Direct medium spiny neurons
- iMSNs
Indirect medium spiny neurons
- ATP
Adenosine Triphosphate
- MCAO
Middle cerebral artery occlusion
- AMPK
AMP activated protein kinase
- I/R
Ischemia–reperfusion
- EA
Electroacupuncture
- MCT1
Monocarboxylate Transporter 1
- ULK1
Unc-51-like kinase 1
- FUNDC1
FUN14 domain containing 1
- LC3
light chain 3
- mTOR
Mammalian target of rapamycin
- MMP
Mitochondrial membrane potential
- TLR4
Toll-like receptor 4
- NF-κB
Nuclear factor kappa B
- MyD88
Myeloid differentiation primary response 88
- HMGB1
High mobility group box 1
- TRAF6
TNF receptor-associated factor 6
- IKK
IκB Kinase
- JNK
c-Jun N-terminal kinase;
- TNF-α
tumor necrosis factor-alpha
- IL-1β
interleukin-1β
- IL-6
interleukin-6
- TNF-β
tumor necrosis factor-β
- JAK
Janus Kinase
- STAT
Signal Transducer and Activator of Transcription
- IL-4
Interleukin-4
- IL-13
Interleukin-13
- PPARγ
Peroxisome proliferator-activated receptor γ
- IL-17
Interleukin-17
- IL-21
Interleukin-21
- IL-22
Interleukin-22
- TGF-β
transforming growth factor-beta
- IL-10
Interleukin-10
- Th17
T helper 17
- CXCL1
C-X-C motif chemokine ligand 1
- CXCL2
C-X-C motif chemokine ligand 2
- IL-17A
interleukin-17A
- Bcl-2
B-cell lymphoma 2
- Bim
Bcl-2 interacting mediator of cell death
- Bad
Bcl-2 antagonist of cell death
- Bax
Bcl-2 associated x protein
- Apaf-1
Apoptotic protease activating factor 1
- ER
Endoplasmic reticulum
- Ca2+
Calcium ion
- UPR
Unfolded protein response
- IRE1
Inositol-requiring enzyme 1
- PERK
Protein kinase r-like endoplasmic reticulum kinase
- ATF6
Activating transcription factor 6
- CHOP
C/EBP-homologous protein
- MAPK
Mitogen-activated protein kinase
- ERK
Extracellular signal-regulated kinase
- Akt
Protein kinase B
- PI3K
Phosphatidylinositol 3-kinase
- PDK1
3-phosphoinositide-dependent kinase 1
- PIP2
Phosphatidylinositol 4,5-bisphosphate
- PIP3
Phosphatidylinositol 3,4,5-trisphosphate
- GSK3β
Glycogen synthase kinase 3 beta
- PTEN
Phosphatase and tensin homolog
- BDNF
Brain-derived neurotrophic factor
- NGF
Nerve growth factor
- NT3
Neurotrophin 3
- NT4
Neurotrophin 4
- CREB
cAMP response element-binding protein
- TrkB
Tropomyosin receptor kinase B
- TrkA
Tropomyosin receptor kinase A
- VEGF
Vascular endothelial growth factor
- Nogo-A
Neurite outgrowth inhibitor A
- NgR1
Nogo-66 receptor 1
- RhoA
Ras homolog gene family member A
- p75NTR
p75 neurotrophin receptor
- ROCK
Rho kinase
- GAP-43
Growth-associated protein 43
- NF-200
Neurofilament 200
- PirB
Paired immunoglobulin-like receptor B
- PSD-95
Postsynaptic density protein 95
- SYN
synapsin
- SDF-1α
Stromal cell-derived factor 1 alpha
- Glu
Glutamate
- GABA
Gamma-aminobutyric acid
- GAD67
Glutamate decarboxylase 67
- GABA-T
GABA-transaminase
- Cl−
Chloride ion
- KCC2
Potassium-Chloride co-transporter 2
- FMA
Fugl-Meyer Assessment
- BI
Barthel Index
- EMG
Electromyography
- fMRI
Functional magnetic resonance imaging
- NDS
Neurological deficit score
- NIHSS
National Institutes of Health Stroke Scale
- TEAS
Transcutaneous electrical acupuncture stimulation
- SRRR
Stroke Recovery and Rehabilitation Roundtable
Glossary
References
1
AfzaliB.LombardiG.LechlerR. I.LordG. M. (2007). The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol.148, 32–46. doi: 10.1111/j.1365-2249.2007.03356.x
2
AlessiD. R.AndjelkovicM.CaudwellB.CronP.MorriceN.CohenP.et al. (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J.15, 6541–6551. doi: 10.1002/j.1460-2075.1996.tb01045.x
3
AliaC.SpallettiC.LaiS.PanareseA.LamolaG.BertolucciF.et al. (2017). Neuroplastic changes following brain ischemia and their contribution to stroke recovery: novel approaches in neurorehabilitation. Front. Cell. Neurosci.11:76. doi: 10.3389/fncel.2017.00076
4
AsanumaC.ThachW. R.JonesE. G. (1983a). Anatomical evidence for segregated focal groupings of efferent cells and their terminal ramifications in the cerebellothalamic pathway of the monkey. Brain Res.286, 267–297. doi: 10.1016/0165-0173(83)90016-4
5
AsanumaC.ThachW. T.JonesE. G. (1983b). Distribution of cerebellar terminations and their relation to other afferent terminations in the ventral lateral thalamic region of the monkey. Brain Res.286, 237–265. doi: 10.1016/0165-0173(83)90015-2
6
BackT.HemmenT.SchülerO. G. (2004). Lesion evolution in cerebral ischemia. J. Neurol.251, 388–397. doi: 10.1007/s00415-004-0399-y
7
BaiY. L.LiL.HuY. S.WuY.XieP. J.WangS. W.et al. (2013). Prospective, randomized controlled trial of physiotherapy and acupuncture on motor function and daily activities in patients with ischemic stroke. J. Altern. Complement. Med.19, 684–689. doi: 10.1089/acm.2012.0578
8
BaiL.ZhangS.ZhouX.LiY.BaiJ. (2019). Brain-derived neurotrophic factor induces thioredoxin-1 expression through TrkB/Akt/CREB pathway in SH-SY5Y cells. Biochimie160, 55–60. doi: 10.1016/j.biochi.2019.02.011
9
BaroneF. C.IrvingE. A.RayA. M.LeeJ. C.KassisS.KumarS.et al. (2001). Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev.21, 129–145. doi: 10.1002/1098-1128(200103)21:2<129::aid-med1003>3.0.co;2-h
10
BartonG. M.MedzhitovR. (2003). Toll-like receptor signaling pathways. Science300, 1524–1525. doi: 10.1126/science.1085536
11
BeckH.YaariY. (2008). Plasticity of intrinsic neuronal properties in CNS disorders. Nat. Rev. Neurosci.9, 357–369. doi: 10.1038/nrn2371
12
BéïqueJ. C.AndradeR. (2003). PSD-95 regulates synaptic transmission and plasticity in rat cerebral cortex. J. Physiol.546, 859–867. doi: 10.1113/jphysiol.2002.031369
13
BernhardtJ.HaywardK. S.KwakkelG.WardN. S.WolfS. L.BorschmannK.et al. (2017). Agreed definitions and a shared vision for new standards in stroke recovery research: the stroke recovery and rehabilitation roundtable taskforce. Int J Stroke12, 444–450. doi: 10.1177/1747493017711816
14
BeyaertC.VasaR.FrykbergG. E. (2015). Gait post-stroke: pathophysiology and rehabilitation strategies. Neurophysiol. Clin.45, 335–355. doi: 10.1016/j.neucli.2015.09.005
15
BhattD.GhoshS. (2014). Regulation of the NF-κB-mediated transcription of inflammatory genes. Front. Immunol.5:71. doi: 10.3389/fimmu.2014.00071
16
BiernaskieJ.ChernenkoG.CorbettD. (2004). Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J. Neurosci.24, 1245–1254. doi: 10.1523/jneurosci.3834-03.2004
17
BinkofskiF.SeitzR. J.ArnoldS.ClassenJ.BeneckeR.FreundH. J. (1996). Thalamic metbolism and corticospinal tract integrity determine motor recovery in stroke. Ann. Neurol.39, 460–470. doi: 10.1002/ana.410390408
18
BirchS.RobinsonN. (2022). Acupuncture as a post-stroke treatment option: a narrative review of clinical guideline recommendations. Phytomedicine104:154297. doi: 10.1016/j.phymed.2022.154297
19
BlasiF.WhalenM. J.AyataC. (2015). Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats. J. Cereb. Blood Flow Metab.35, 977–984. doi: 10.1038/jcbfm.2015.7
20
BlissT. M.SapolskyR. M. (2001). Interactions among glucose, lactate and adenosine regulate energy substrate utilization in hippocampal cultures. Brain Res.899, 134–141. doi: 10.1016/s0006-8993(01)02218-1
21
Böcker-MeffertS.RosenstielP.RöhlC.WarnekeN.Held-FeindtJ.SieversJ.et al. (2002). Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest. Ophthalmol. Vis. Sci.43, 2021–2026.
22
BrownstoneR. M.ChopekJ. W. (2018). Reticulospinal systems for tuning motor commands. Front. Neural Circuits12:30. doi: 10.3389/fncir.2018.00030
23
CaggianoV.LeirasR.Goñi-ErroH.MasiniD.BellarditaC.BouvierJ.et al. (2018). Midbrain circuits that set locomotor speed and gait selection. Nature553, 455–460. doi: 10.1038/nature25448
24
CaiY.ZhangC. S.LiuS.WenZ.ZhangA. L.GuoX.et al. (2017). Electroacupuncture for Poststroke spasticity: a systematic review and meta-analysis. Arch. Phys. Med. Rehabil.98, 2578–2589. doi: 10.1016/j.apmr.2017.03.023
25
ChalifouxJ. R.CarterA. G. (2010). GABAB receptors modulate NMDA receptor calcium signals in dendritic spines. Neuron66, 101–113. doi: 10.1016/j.neuron.2010.03.012
26
ChenT.YuY.TangL. J.KongL.ZhangC. H.ChuH. Y.et al. (2017). Neural stem cells over-expressing brain-derived neurotrophic factor promote neuronal survival and cytoskeletal protein expression in traumatic brain injury sites. Neural Regen. Res.12, 433–439. doi: 10.4103/1673-5374.202947
27
ColemanE. R.MoudgalR.LangK.HyacinthH. I.AwosikaO. O.KisselaB. M.et al. (2017). Early rehabilitation after stroke: a narrative review. Curr. Atheroscler. Rep.19:59. doi: 10.1007/s11883-017-0686-6
28
CorbettaM.RamseyL.CallejasA.BaldassarreA.HackerC. D.SiegelJ. S.et al. (2015). Common behavioral clusters and subcortical anatomy in stroke. Neuron85, 927–941. doi: 10.1016/j.neuron.2015.02.027
29
CôtéM. P.MurrayL. M.KnikouM. (2018). Spinal control of locomotion: individual neurons, their circuits and functions. Front. Physiol.9:784. doi: 10.3389/fphys.2018.00784
30
CramerS. C.KoroshetzW. J.FinklesteinS. P. (2007). The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke38, 1393–1395. doi: 10.1161/01.Str.0000260087.67462.80
31
CreamerM.CloudG.KossmehlP.YochelsonM.FranciscoG. E.WardA. B.et al. (2018). Effect of intrathecal baclofen on pain and quality of life in Poststroke spasticity. Stroke49, 2129–2137. doi: 10.1161/strokeaha.118.022255
32
DalyJ. J.WolpawJ. R. (2008). Brain-computer interfaces in neurological rehabilitation. Lancet Neurol.7, 1032–1043. doi: 10.1016/s1474-4422(08)70223-0
33
DarnayB. G.NiJ.MooreP. A.AggarwalB. B. (1999). Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J. Biol. Chem.274, 7724–7731. doi: 10.1074/jbc.274.12.7724
34
DattaS. R.DudekH.TaoX.MastersS.FuH.GotohY.et al. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell91, 231–241. doi: 10.1016/s0092-8674(00)80405-5
35
DautanD.KovácsA.BayasgalanT.Diaz-AcevedoM. A.PalB.Mena-SegoviaJ. (2021). Modulation of motor behavior by the mesencephalic locomotor region. Cell Rep.36:109594. doi: 10.1016/j.celrep.2021.109594
36
DavisR. T.ChurchillD. L.BadgerG. J.DunnJ.LangevinH. M. (2012). A new method for quantifying the needling component of acupuncture treatments. Acupunct. Med.30, 113–119. doi: 10.1136/acupmed-2011-010111
37
DengB.BaiF.ZhouH.ZhouD.MaZ.XiongL.et al. (2016). Electroacupuncture enhances rehabilitation through miR-181b targeting PirB after ischemic stroke. Sci. Rep.6:38997. doi: 10.1038/srep38997
38
DengY.GuoF.HanX.HuangX. (2021). Repetitive transcranial magnetic stimulation increases neurological function and endogenous neural stem cell migration via the SDF-1α/CXCR4 axis after cerebral infarction in rats. Exp. Ther. Med.22:1037. doi: 10.3892/etm.2021.10469
39
DengB.LiL.GouX.XuH.ZhaoZ.WangQ.et al. (2018). TAT-PEP enhanced neurobehavioral functional recovery by facilitating axonal regeneration and corticospinal tract projection after stroke. Mol. Neurobiol.55, 652–667. doi: 10.1007/s12035-016-0301-9
40
DengL.WangC.SpencerE.YangL.BraunA.YouJ.et al. (2000). Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell103, 351–361. doi: 10.1016/s0092-8674(00)00126-4
41
Di PinoG.PellegrinoG.AssenzaG.CaponeF.FerreriF.FormicaD.et al. (2014). Modulation of brain plasticity in stroke: a novel model for neurorehabilitation. Nat. Rev. Neurol.10, 597–608. doi: 10.1038/nrneurol.2014.162
42
DimyanM. A.CohenL. G. (2011). Neuroplasticity in the context of motor rehabilitation after stroke. Nat. Rev. Neurol.7, 76–85. doi: 10.1038/nrneurol.2010.200
43
DolatiS.AhmadiM.KhaliliM.TaheraghdamA. A.SiahmansouriH.BabalooZ.et al. (2018). Peripheral Th17/Treg imbalance in elderly patients with ischemic stroke. Neurol. Sci.39, 647–654. doi: 10.1007/s10072-018-3250-4
44
Duc NguyenM.Van TranT.Vinh NguyenQ.Khac NguyenN.Truong VuS.Trong NguyenL.et al. (2023). Effectiveness on post-stroke hemiplegia in patients: electroacupuncture plus cycling electroacupuncture alone. J. Tradit. Chin. Med.43, 352–358. doi: 10.19852/j.cnki.jtcm.2023.02.006
45
DumR. P.StrickP. L. (2003). An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex. J. Neurophysiol.89, 634–639. doi: 10.1152/jn.00626.2002
46
EbbesenC. L.BrechtM. (2017). Motor cortex - to act or not to act?Nat. Rev. Neurosci.18, 694–705. doi: 10.1038/nrn.2017.119
47
FalconeN.LeoF.ChisariC.DaliseS. (2024). Long-term Management of Post-Stroke Spasticity with botulinum toxin: a retrospective study. Toxins (Basel).16:383. doi: 10.3390/toxins16090383
48
FanT. K.GundimedaU.MackW. J.GopalakrishnaR. (2016). Counteraction of Nogo-a and axonal growth inhibitors by green tea polyphenols and other natural products. Neural Regen. Res.11, 545–546. doi: 10.4103/1673-5374.180729
49
FerezouI.HaissF.GentetL. J.AronoffR.WeberB.PetersenC. C. (2007). Spatiotemporal dynamics of cortical sensorimotor integration in behaving mice. Neuron56, 907–923. doi: 10.1016/j.neuron.2007.10.007
50
Fugl-MeyerA. R.JääsköL.LeymanI.OlssonS.SteglindS. (1975). The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand. J. Rehabil. Med.7, 13–31.
51
GanleyI. G.LamD. H.WangJ.DingX.ChenS.JiangX. (2009). ULK1·ATG13·FIP200 complex mediates mTOR Signaling and is essential for autophagy*. J. Biol. Chem.284, 12297–12305. doi: 10.1074/jbc.M900573200
52
GaoH.GaoX.LiangG.MaB. X. (2012). Contra-lateral needling in the treatment of hemiplegia due to acute ischemic stroke. Acupunct Electrother. Res.37, 1–12. doi: 10.3727/036012912x13831831256041
53
GaoY.SignoreA. P.YinW.CaoG.YinX. M.SunF.et al. (2005). Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J. Cereb. Blood Flow Metab.25, 694–712. doi: 10.1038/sj.jcbfm.9600062
54
GBD 2019 Stroke Collaborators (2021). Stroke collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol.20, 795–820. doi: 10.1016/s1474-4422(21)00252-0
55
GeorgeP. M.SteinbergG. K. (2015). Novel stroke therapeutics: Unraveling stroke pathophysiology and its impact on clinical treatments. Neuron87, 297–309. doi: 10.1016/j.neuron.2015.05.041
56
GibbsW. S.WeberR. A.SchnellmannR. G.AdkinsD. L. (2016). Disrupted mitochondrial genes and inflammation following stroke. Life Sci.166, 139–148. doi: 10.1016/j.lfs.2016.09.021
57
GongJ.WangG.WangY.ChenX.ChenY.MengQ.et al. (2022). Nowcasting and forecasting the care needs of the older population in China: analysis of data from the China health and retirement longitudinal study (CHARLS). Lancet Public Health7, e1005–e1013. doi: 10.1016/s2468-2667(22)00203-1
58
GraciesJ. M.BrashearA.JechR.McallisterP.BanachM.ValkovicP.et al. (2015). Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. Lancet Neurol.14, 992–1001. doi: 10.1016/s1474-4422(15)00216-1
59
GremelC. M.CostaR. M. (2013). Orbitofrontal and striatal circuits dynamically encode the shift between goal-directed and habitual actions. Nat. Commun.4:2264. doi: 10.1038/ncomms3264
60
GrillnerS.RobertsonB.KotaleskiJ. H. (2020). Basal ganglia-a motion perspective. Compr. Physiol.10, 1241–1275. doi: 10.1002/cphy.c190045
61
GrinevichV.BrechtM.OstenP. (2005). Monosynaptic pathway from rat vibrissa motor cortex to facial motor neurons revealed by lentivirus-based axonal tracing. J. Neurosci.25, 8250–8258. doi: 10.1523/jneurosci.2235-05.2005
62
GurneyK. N.HumphriesM. D.RedgraveP. (2015). A new framework for cortico-striatal plasticity: behavioural theory meets in vitro data at the reinforcement-action interface. PLoS Biol.13:e1002034. doi: 10.1371/journal.pbio.1002034
63
HanB.LuY.ZhaoH.WangY.LiL.WangT. (2015). Electroacupuncture modulated the inflammatory reaction in MCAO rats via inhibiting the TLR4/NF-κB signaling pathway in microglia. Int. J. Clin. Exp. Pathol.8, 11199–11205.
64
HanY.YuanM.GuoY. S.ShenX. Y.GaoZ. K.BiX. (2021). Mechanism of endoplasmic reticulum stress in cerebral ischemia. Front. Cell. Neurosci.15:704334. doi: 10.3389/fncel.2021.704334
65
HandleyA.MedcalfP.HellierK.DuttaD. (2009). Movement disorders after stroke. Age Ageing38, 260–266. doi: 10.1093/ageing/afp020
66
HansenK. B.WollmuthL. P.BowieD.FurukawaH.MennitiF. S.SobolevskyA. I.et al. (2021). Structure, function, and pharmacology of glutamate receptor ion channels. Pharmacol. Rev.73, 298–487. doi: 10.1124/pharmrev.120.000131
67
HardieD. G.RossF. A.HawleyS. A. (2012). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol.13, 251–262. doi: 10.1038/nrm3311
68
HauptM.ZechmeisterB.BoscheB.LieschkeS.ZhengX.ZhangL.et al. (2020). Lithium enhances post-stroke blood-brain barrier integrity, activates the MAPK/ERK1/2 pathway and alters immune cell migration in mice. Neuropharmacology181:108357. doi: 10.1016/j.neuropharm.2020.108357
69
HeY.GaoY.ZhangQ.ZhouG.CaoF.YaoS. (2020). IL-4 switches microglia/macrophage M1/M2 polarization and alleviates neurological damage by modulating the JAK1/STAT6 pathway following ICH. Neuroscience437, 161–171. doi: 10.1016/j.neuroscience.2020.03.008
70
HeZ.NingN.ZhouQ.KhoshnamS. E.FarzanehM. (2020). Mitochondria as a therapeutic target for ischemic stroke. Free Radic. Biol. Med.146, 45–58. doi: 10.1016/j.freeradbiomed.2019.11.005
71
HofmeijerJ.Van PuttenM. J. (2012). Ischemic cerebral damage: an appraisal of synaptic failure. Stroke43, 607–615. doi: 10.1161/strokeaha.111.632943
72
HoltmanI. R.SkolaD.GlassC. K. (2017). Transcriptional control of microglia phenotypes in health and disease. J. Clin. Invest.127, 3220–3229. doi: 10.1172/jci90604
73
HorieN.MorofujiY.IkiY.SadakataE.KanamotoT.TateishiY.et al. (2019). Impact of basal ganglia damage after successful endovascular recanalization for acute ischemic stroke involving lenticulostriate arteries. J. Neurosurg.132, 1880–1888. doi: 10.3171/2019.3.Jns182909
74
HuX.LiouA. K.LeakR. K.XuM.AnC.SuenagaJ.et al. (2014). Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog. Neurobiol.119-120, 60–84. doi: 10.1016/j.pneurobio.2014.06.002
75
HuangS.YangZ. J.YuC.SinicropeF. A. (2011). Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62/sequestosome 1. J. Biol. Chem.286, 40002–40012. doi: 10.1074/jbc.M111.297432
76
HubliM.BolligerM.LimacherE.LuftA. R.DietzV. (2012). Spinal neuronal dysfunction after stroke. Exp. Neurol.234, 153–160. doi: 10.1016/j.expneurol.2011.12.025
77
IlgW.GieseM. A.GizewskiE. R.SchochB.TimmannD. (2008). The influence of focal cerebellar lesions on the control and adaptation of gait. Brain131, 2913–2927. doi: 10.1093/brain/awn246
78
JiangM.LiJ.PengQ.LiuY.LiuW.LuoC.et al. (2014). Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J. Neuroinflammation11:167. doi: 10.1186/s12974-014-0167-6
79
JoyM. T.CarmichaelS. T. (2021). Encouraging an excitable brain state: mechanisms of brain repair in stroke. Nat. Rev. Neurosci.22, 38–53. doi: 10.1038/s41583-020-00396-7
80
Kaidanovich-BeilinO.WoodgettJ. R. (2011). GSK-3: functional insights from cell biology and animal models. Front. Mol. Neurosci.4:40. doi: 10.3389/fnmol.2011.00040
81
KailaK. (1994). Ionic basis of GABAA receptor channel function in the nervous system. Prog. Neurobiol.42, 489–537. doi: 10.1016/0301-0082(94)90049-3
82
Keren-ShaulH.SpinradA.WeinerA.Matcovitch-NatanO.Dvir-SzternfeldR.UllandT. K.et al. (2017). A unique microglia type associated with restricting development of Alzheimer's disease. Cell169, 1276–1290.e1217. doi: 10.1016/j.cell.2017.05.018
83
KimY. R.AhnS. M.PakM. E.LeeH. J.JungD. H.ShinY. I.et al. (2018). Potential benefits of mesenchymal stem cells and electroacupuncture on the trophic factors associated with neurogenesis in mice with ischemic stroke. Sci. Rep.8:2044. doi: 10.1038/s41598-018-20481-3
84
KimJ. H.ChoiK. H.JangY. J.KimH. N.BaeS. S.ChoiB. T.et al. (2013). Electroacupuncture preconditioning reduces cerebral ischemic injury via BDNF and SDF-1α in mice. BMC Complement. Altern. Med.13:22. doi: 10.1186/1472-6882-13-22
85
KimL. H.HeckD. H.SillitoeR. V. (2024). Cerebellar functions beyond movement and learning. Annu. Rev. Neurosci.47, 145–166. doi: 10.1146/annurev-neuro-100423-104943
86
KimY. R.KimH. N.AhnS. M.ChoiY. H.ShinH. K.ChoiB. T. (2014). Electroacupuncture promotes post-stroke functional recovery via enhancing endogenous neurogenesis in mouse focal cerebral ischemia. PLoS One9:e90000. doi: 10.1371/journal.pone.0090000
87
KimJ.KunduM.ViolletB.GuanK. L. (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol.13, 132–141. doi: 10.1038/ncb2152
88
KinnischtzkeA. K.SimonsD. J.FanselowE. E. (2014). Motor cortex broadly engages excitatory and inhibitory neurons in somatosensory barrel cortex. Cereb. Cortex24, 2237–2248. doi: 10.1093/cercor/bht085
89
KlausA.Alves Da SilvaJ.CostaR. M. (2019). What, if, and when to move: basal ganglia circuits and self-paced action initiation. Annu. Rev. Neurosci.42, 459–483. doi: 10.1146/annurev-neuro-072116-031033
90
KrakauerJ. W.CarmichaelS. T.CorbettD.WittenbergG. F. (2012). Getting neurorehabilitation right: what can be learned from animal models?Neurorehabil. Neural Repair26, 923–931. doi: 10.1177/1545968312440745
91
KravitzA. V.FreezeB. S.ParkerP. R.KayK.ThwinM. T.DeisserothK.et al. (2010). Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature466, 622–626. doi: 10.1038/nature09159
92
LanL.TaoJ.ChenA.XieG.HuangJ.LinJ.et al. (2013). Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-κB pathway. Int. J. Mol. Med.31, 75–80. doi: 10.3892/ijmm.2012.1184
93
LaplaneD.TalairachJ.MeiningerV.BancaudJ.BouchareineA. (1977). Motor consequences of motor area ablations in man. J. Neurol. Sci.31, 29–49. doi: 10.1016/0022-510x(77)90004-1
94
LarreaA.ElexpeA.DÃez-MartÃnE.TorrecillaM.AstigarragaE.Barreda-GómezG. (2023). Neuroinflammation in the evolution of motor function in stroke and trauma patients: treatment and potential biomarkers. Curr. Issues Mol. Biol.45, 8552–8585. doi: 10.3390/cimb45110539
95
LarteyF. M.AhnG. O.AliR.RosenblumS.MiaoZ.ArkseyN.et al. (2014). The relationship between serial [(18) F]PBR06 PET imaging of microglial activation and motor function following stroke in mice. Mol. Imaging Biol.16, 821–829. doi: 10.1007/s11307-014-0745-0
96
LeeJ. M.GrabbM. C.ZipfelG. J.ChoiD. W. (2000). Brain tissue responses to ischemia. J. Clin. Invest.106, 723–731. doi: 10.1172/jci11003
97
LeeI. H.HuangS. S.ChuangC. Y.LiaoK. H.ChangL. H.ChuangC. C.et al. (2017). Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke. Sci. Rep.7:1943. doi: 10.1038/s41598-017-02137-w
98
LeeJ. H.KimK. Y.LeeY. K.ParkS. Y.KimC. D.LeeW. S.et al. (2004). Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats. J. Pharmacol. Exp. Ther.308, 896–903. doi: 10.1124/jpet.103.061853
99
LeeS. E.LeeY.LeeG. H. (2019). The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain. Arch. Pharm. Res.42, 1031–1039. doi: 10.1007/s12272-019-01196-z
100
LeirasR.CreggJ. M.KiehnO. (2022). Brainstem circuits for locomotion. Annu. Rev. Neurosci.45, 63–85. doi: 10.1146/annurev-neuro-082321-025137
101
LemonR. N. (2008). Descending pathways in motor control. Annu. Rev. Neurosci.31, 195–218. doi: 10.1146/annurev.neuro.31.060407.125547
102
LiS.ChenY. T.FranciscoG. E.ZhouP.RymerW. Z. (2019). A unifying pathophysiological account for post-stroke spasticity and disordered motor control. Front. Neurol.10:468. doi: 10.3389/fneur.2019.00468
103
LiN.ChenT. W.GuoZ. V.GerfenC. R.SvobodaK. (2015). A motor cortex circuit for motor planning and movement. Nature519, 51–56. doi: 10.1038/nature14178
104
LiD. P.ChenS. R.PanY. Z.LeveyA. I.PanH. L. (2002). Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J. Physiol.543, 807–818. doi: 10.1113/jphysiol.2002.020644
105
LiD.WangD.ZhouY.ZhangY.YangS.DongX.et al. (2024). Neural effects of acupuncture on stroke patients with motor dysfunction: an activation likelihood estimation meta-analysis. Front. Neurol.15:1453935. doi: 10.3389/fneur.2024.1453935
106
LiJ.YenC.LiawD.PodsypaninaK.BoseS.WangS. I.et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science275, 1943–1947. doi: 10.1126/science.275.5308.1943
107
LieszA.Suri-PayerE.VeltkampC.DoerrH.SommerC.RivestS.et al. (2009). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med.15, 192–199. doi: 10.1038/nm.1927
108
LindvallO.KokaiaZ. (2010). Stem cells in human neurodegenerative disorders--time for clinical translation?J. Clin. Invest.120, 29–40. doi: 10.1172/jci40543
109
LiuL.FengD.ChenG.ChenM.ZhengQ.SongP.et al. (2012). Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol.14, 177–185. doi: 10.1038/ncb2422
110
LiuD.GuY.WangW.ChenW. (2020). Astragalin alleviates ischemia/reperfusion-induced brain injury via suppression of endoplasmic reticulum stress. Mol. Med. Rep.22, 4070–4078. doi: 10.3892/mmr.2020.11448
111
LiuX.KenkareK.LiS.DesaiV.WongJ.LuoX.et al. (2015). Increased Th17/Treg ratio in Poststroke fatigue. Mediat. Inflamm.2015:931398. doi: 10.1155/2015/931398
112
LiuT.LiX.ZhouX.ChenW.WenA.LiuM.et al. (2025). PI3K/AKT signaling and neuroprotection in ischemic stroke: molecular mechanisms and therapeutic perspectives. Neural Regen. Res.20, 2758–2775. doi: 10.4103/nrr.Nrr-d-24-00568
113
LiuW.WangX.YangS.HuangJ.XueX.ZhengY.et al. (2016a). Electroacupunctre improves motor impairment via inhibition of microglia-mediated neuroinflammation in the sensorimotor cortex after ischemic stroke. Life Sci.151, 313–322. doi: 10.1016/j.lfs.2016.01.045
114
LiuW.WangX.ZhengY.ShangG.HuangJ.TaoJ.et al. (2016b). Electroacupuncture inhibits inflammatory injury by targeting the miR-9-mediated NF-κB signaling pathway following ischemic stroke. Mol. Med. Rep.13, 1618–1626. doi: 10.3892/mmr.2015.4745
115
Lloyd-JonesD.AdamsR.CarnethonM.De SimoneG.FergusonT. B.FlegalK.et al. (2009). Heart disease and stroke statistics--2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation119, 480–486. doi: 10.1161/circulationaha.108.191259
116
LouY.LiuZ.JiY.ChengJ.ZhaoC.LiL. (2024). Efficacy and safety of very early rehabilitation for acute ischemic stroke: a systematic review and meta-analysis. Front. Neurol.15:1423517. doi: 10.3389/fneur.2024.1423517
117
LoveS. (2003). Apoptosis and brain ischaemia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry27, 267–282. doi: 10.1016/s0278-5846(03)00022-8
118
LuY.ZhaoH.WangY.HanB.WangT.ZhaoH.et al. (2015). Electro-acupuncture up-regulates astrocytic MCT1 expression to improve neurological deficit in middle cerebral artery occlusion rats. Life Sci.134, 68–72. doi: 10.1016/j.lfs.2015.05.014
119
LuitseM. J.BiesselsG. J.RuttenG. E.KappelleL. J. (2012). Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol.11, 261–271. doi: 10.1016/s1474-4422(12)70005-4
120
LukacovaN.KisuckaA.Kiss BimbovaK.BacovaM.IleninovaM.KurucT.et al. (2021). Glial-neuronal interactions in pathogenesis and treatment of spinal cord injury. Int. J. Mol. Sci.22:577. doi: 10.3390/ijms222413577
121
LuoJ.HuX.ZhangL.LiL.ZhengH.LiM.et al. (2014). Physical exercise regulates neural stem cells proliferation and migration via SDF-1α/CXCR4 pathway in rats after ischemic stroke. Neurosci. Lett.578, 203–208. doi: 10.1016/j.neulet.2014.06.059
122
LvQ.XuG.PanY.LiuT.LiuX.MiaoL.et al. (2021). Effect of acupuncture on neuroplasticity of stroke patients with motor dysfunction: a meta-analysis of fMRI studies. Neural Plast.2021:8841720. doi: 10.1155/2021/8841720
123
LydenP. D.LambJ.KothariS.ToossiS.BoitanoP.RajputP. S. (2019). Differential effects of hypothermia on neurovascular unit determine protective or toxic results: toward optimized therapeutic hypothermia. J. Cereb. Blood Flow Metab.39, 1693–1709. doi: 10.1177/0271678x18814614
124
MaehamaT.DixonJ. E. (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem.273, 13375–13378. doi: 10.1074/jbc.273.22.13375
125
MarciniakS. J.RonD. (2006). Endoplasmic reticulum stress signaling in disease. Physiol. Rev.86, 1133–1149. doi: 10.1152/physrev.00015.2006
126
MarkusA.PatelT. D.SniderW. D. (2002). Neurotrophic factors and axonal growth. Curr. Opin. Neurobiol.12, 523–531. doi: 10.1016/s0959-4388(02)00372-0
127
MarshallR. S.PereraG. M.LazarR. M.KrakauerJ. W.ConstantineR. C.DelapazR. L. (2000). Evolution of cortical activation during recovery from corticospinal tract infarction. Stroke31, 656–661. doi: 10.1161/01.str.31.3.656
128
MatsushitaM.OkadoN. (1981). Spinocerebellar projections to lobules I and II of the anterior lobe in the cat, as studied by retrograde transport of horseradish peroxidase. J. Comp. Neurol.197, 411–424. doi: 10.1002/cne.901970305
129
MccraryM. R.JessonK.WeiZ. Z.LogunM.LenearC.TanS.et al. (2020). Cortical transplantation of brain-mimetic glycosaminoglycan scaffolds and neural progenitor cells promotes vascular regeneration and functional recovery after ischemic stroke in mice. Adv. Healthc. Mater.9:e1900285. doi: 10.1002/adhm.201900285
130
McgeorgeA. J.FaullR. L. (1989). The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience29, 503–537. doi: 10.1016/0306-4522(89)90128-0
131
MenonP.VucicS. (2021). The upper motor neuron-improved knowledge from ALS and related clinical disorders. Brain Sci.11:958. doi: 10.3390/brainsci11080958
132
MinK. J.JeongH. K.KimB.HwangD. H.ShinH. Y.NguyenA. T.et al. (2012). Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury. J. Neuroinflammation9:100. doi: 10.1186/1742-2094-9-100
133
MortonS. M.BastianA. J. (2004). Cerebellar control of balance and locomotion. Neuroscientist10, 247–259. doi: 10.1177/1073858404263517
134
MuJ. D.MaL. X.ZhangZ.QianX.ZhangQ. Y.MaL. H.et al. (2023). The factors affecting neurogenesis after stroke and the role of acupuncture. Front. Neurol.14:1082625. doi: 10.3389/fneur.2023.1082625
135
MuJ. D.MaL. X.ZhangZ.YuW. Y.SunT. Y.QianX.et al. (2022). Acupuncture alleviates spinal hyperreflexia and motor dysfunction in post-ischemic stroke rats with spastic hypertonia via KCC2-mediated spinal GABA(a) activation. Exp. Neurol.354:114027. doi: 10.1016/j.expneurol.2022.114027
136
MuirK. W.BultersD.WillmotM.SpriggN.DixitA.WardN.et al. (2020). Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2). J. Neurol. Neurosurg. Psychiatry91, 396–401. doi: 10.1136/jnnp-2019-322515
137
NakayamaH.JørgensenH. S.RaaschouH. O.OlsenT. S. (1994). Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch. Phys. Med. Rehabil.75, 394–398. doi: 10.1016/0003-9993(94)90161-9
138
NamuraS.IiharaK.TakamiS.NagataI.KikuchiH.MatsushitaK.et al. (2001). Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl. Acad. Sci. USA98, 11569–11574. doi: 10.1073/pnas.181213498
139
NegroF.FarinaD. (2011). Linear transmission of cortical oscillations to the neural drive to muscles is mediated by common projections to populations of motoneurons in humans. J. Physiol.589, 629–637. doi: 10.1113/jphysiol.2010.202473
140
NieZ.HuC.MiaoH.WuF. (2024). Electroacupuncture protects against the striatum of ischemia stroke by inhibiting the HMGB1/RAGE/p-JNK signaling pathways. J. Chem. Neuroanat.136:102376. doi: 10.1016/j.jchemneu.2023.102376
141
NielsenJ. B. (2016). Human spinal motor control. Annu. Rev. Neurosci.39, 81–101. doi: 10.1146/annurev-neuro-070815-013913
142
NishimuraY.OnoeH.MorichikaY.PerfilievS.TsukadaH.IsaT. (2007). Time-dependent central compensatory mechanisms of finger dexterity after spinal cord injury. Science318, 1150–1155. doi: 10.1126/science.1147243
143
NudoR. J.WiseB. M.SifuentesF.MillikenG. W. (1996). Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science272, 1791–1794. doi: 10.1126/science.272.5269.1791
144
O’DonoghueD. L.Kartje-TillotsonG.CastroA. J. (1987). Forelimb motor cortical projections in normal rats and after neonatal hemicerebellectomy: an anatomical study based upon the axonal transport of WGA/HRP. J. Comp. Neurol.256, 274–283. doi: 10.1002/cne.902560207
145
OstenP.MargrieT. W. (2013). Mapping brain circuitry with a light microscope. Nat. Methods10, 515–523. doi: 10.1038/nmeth.2477
146
OtalR.BurgayaF.FrisénJ.SorianoE.MartÃnezA. (2006). Ephrin-A5 modulates the topographic mapping and connectivity of commissural axons in murine hippocampus. Neuroscience141, 109–121. doi: 10.1016/j.neuroscience.2006.03.052
147
ParkJ. (2016). Movement disorders following cerebrovascular lesion in the basal ganglia circuit. J. Mov. Disord.9, 71–79. doi: 10.14802/jmd.16005
148
PascotiniE. T.FloresA. E.KeglerA.GabbiP.BochiG. V.AlgarveT. D.et al. (2015). Apoptotic markers and DNA damage are related to late phase of stroke: involvement of dyslipidemia and inflammation. Physiol. Behav.151, 369–378. doi: 10.1016/j.physbeh.2015.08.005
149
PengY.LiN.DuX.ZhangG.HuangS.MaJ. (2024). Acupuncture combined with mirror therapy for post-stroke dyskinesia: a meta-analysis and systematic review. Medicine (Baltimore)103:e38733. doi: 10.1097/md.0000000000038733
150
PetiW.PageR. (2013). Molecular basis of MAP kinase regulation. Protein Sci.22, 1698–1710. doi: 10.1002/pro.2374
151
PetrofI.ViaeneA. N.ShermanS. M. (2015). Properties of the primary somatosensory cortex projection to the primary motor cortex in the mouse. J. Neurophysiol.113, 2400–2407. doi: 10.1152/jn.00949.2014
152
PlateK. H.BeckH.DannerS.AllegriniP. R.WiessnerC. (1999). Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J. Neuropathol. Exp. Neurol.58, 654–666. doi: 10.1097/00005072-199906000-00010
153
QiX. J.WildeyG. M.HoweP. H. (2006). Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J. Biol. Chem.281, 813–823. doi: 10.1074/jbc.M505546200
154
QiuX.GaoY.ZhangZ.ChengS.ZhangS. (2021). Fire acupuncture versus conventional acupuncture to treat spasticity after stroke: a systematic review and meta-analysis. PLoS One16:e0249313. doi: 10.1371/journal.pone.0249313
155
RaffinE.HummelF. C. (2018). Restoring motor functions after stroke: multiple approaches and opportunities. Neuroscientist24, 400–416. doi: 10.1177/1073858417737486
156
RenX.GaoX.LiZ.DingY.XuA.DuL.et al. (2024). Electroacupuncture ameliorates neuroinflammation by inhibiting TRPV4 channel in ischemic stroke. CNS Neurosci. Ther.30:e14618. doi: 10.1111/cns.14618
157
RenL.ZhangW. A.FangN. Y.WangJ. X. (2008). The influence of electro-acupuncture on neural plasticity in acute cerebral infarction. Neurol. Res.30, 985–989. doi: 10.1179/174313208x325182
158
RenauldJ. C. (2003). Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol.3, 667–676. doi: 10.1038/nri1153
159
RidderD. A.SchwaningerM. (2009). NF-kappaB signaling in cerebral ischemia. Neuroscience158, 995–1006. doi: 10.1016/j.neuroscience.2008.07.007
160
RissanenA.SiveniusJ.JolkkonenJ. (2006). Prolonged bihemispheric alterations in unfolded protein response related gene expression after experimental stroke. Brain Res.1087, 60–66. doi: 10.1016/j.brainres.2006.02.095
161
RisticA.MarinkovicJ.DragasevicN.StanisavljevicD.KosticV. (2002). Long-term prognosis of vascular hemiballismus. Stroke33, 2109–2111. doi: 10.1161/01.str.0000022810.76115.c0
162
RiveraC.VoipioJ.KailaK. (2005). Two developmental switches in GABAergic signalling: the K+-cl- cotransporter KCC2 and carbonic anhydrase CAVII. J. Physiol.562, 27–36. doi: 10.1113/jphysiol.2004.077495
163
RoumesH.DumontU.SanchezS.MazuelL.BlancJ.RaffardG.et al. (2021). Neuroprotective role of lactate in rat neonatal hypoxia-ischemia. J. Cereb. Blood Flow Metab.41, 342–358. doi: 10.1177/0271678x20908355
164
SchaechterJ. D.ConnellB. D.StasonW. B.KaptchukT. J.KrebsD. E.MacklinE. A.et al. (2007). Correlated change in upper limb function and motor cortex activation after verum and sham acupuncture in patients with chronic stroke. J. Altern. Complement. Med.13, 527–532. doi: 10.1089/acm.2007.6316
165
SchieberM. H.PoliakovA. V. (1998). Partial inactivation of the primary motor cortex hand area: effects on individuated finger movements. J. Neurosci.18, 9038–9054. doi: 10.1523/jneurosci.18-21-09038.1998
166
SchwabM. E.StrittmatterS. M. (2014). Nogo limits neural plasticity and recovery from injury. Curr. Opin. Neurobiol.27, 53–60. doi: 10.1016/j.conb.2014.02.011
167
SegalM. (2018). Muscle Overactivity in the upper motor neuron syndrome: pathophysiology. Phys. Med. Rehabil. Clin. N. Am.29, 427–436. doi: 10.1016/j.pmr.2018.04.005
168
ShiH.WangX. L.QuanH. F.YanL.PeiX. Y.WangR.et al. (2019). Effects of betaine on LPS-stimulated activation of microglial M1/M2 phenotypes by suppressing TLR4/NF-κB pathways in N9 cells. Molecules24:367. doi: 10.3390/molecules24020367
169
SifatA. E.NozohouriS.ArchieS. R.ChowdhuryE. A.AbbruscatoT. J. (2022). Brain energy metabolism in ischemic stroke: effects of smoking and diabetes. Int. J. Mol. Sci.23:512. doi: 10.3390/ijms23158512
170
SoekadarS. R.BirbaumerN.SlutzkyM. W.CohenL. G. (2015). Brain-machine interfaces in neurorehabilitation of stroke. Neurobiol. Dis.83, 172–179. doi: 10.1016/j.nbd.2014.11.025
171
SongH. Y.RégnierC. H.KirschningC. J.GoeddelD. V.RotheM. (1997). Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-Jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA94, 9792–9796. doi: 10.1073/pnas.94.18.9792
172
SquairJ. W.MilanoM.De CoucyA.GautierM.SkinniderM. A.JamesN. D.et al. (2023). Recovery of walking after paralysis by regenerating characterized neurons to their natural target region. Science381, 1338–1345. doi: 10.1126/science.adi6412
173
StierschneiderA.WiesnerC. (2023). Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions. Front. Immunol.14:1264889. doi: 10.3389/fimmu.2023.1264889
174
StinearC. (2010). Prediction of recovery of motor function after stroke. Lancet Neurol.9, 1228–1232. doi: 10.1016/s1474-4422(10)70247-7
175
StockingerB.VeldhoenM. (2007). Differentiation and function of Th17 T cells. Curr. Opin. Immunol.19, 281–286. doi: 10.1016/j.coi.2007.04.005
176
StokoeD.StephensL. R.CopelandT.GaffneyP. R.ReeseC. B.PainterG. F.et al. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science277, 567–570. doi: 10.1126/science.277.5325.567
177
SulterG.SteenC.De KeyserJ. (1999). Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke30, 1538–1541. doi: 10.1161/01.str.30.8.1538
178
SunT. Y.MaL. X.MuJ. D.ZhangZ.YuW. Y.QianX.et al. (2022). Acupuncture improves the structure of spastic muscle and decreases spasticity by enhancing GABA, KCC2, and GABAAγ2 in the brainstem in rats after ischemic stroke. Neuroreport33, 399–407. doi: 10.1097/wnr.0000000000001798
179
TangY.YuP.ChengL. (2017). Current progress in the derivation and therapeutic application of neural stem cells. Cell Death Dis.8:e3108. doi: 10.1038/cddis.2017.504
180
TaoY. X.WuY. H.ZhuG. Q.WangM. (2023). Efficacy of acupuncture in the treatment of limb dyskinesia after stroke: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci.27, 10985–10993. doi: 10.26355/eurrev_202311_34467
181
TarsaL.GodaY. (2002). Synaptophysin regulates activity-dependent synapse formation in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A.99, 1012–1016. doi: 10.1073/pnas.022575999
182
TaubE.UswatteG.ElbertT. (2002). New treatments in neurorehabilitation founded on basic research. Nat. Rev. Neurosci.3, 228–236. doi: 10.1038/nrn754
183
TekaW. W.HamadeK. C.BarnettW. H.KimT.MarkinS. N.RybakI. A.et al. (2017). From the motor cortex to the movement and back again. PLoS One12:e0179288. doi: 10.1371/journal.pone.0179288
184
TianL.DuX.WangJ.SunR.ZhangZ.YuanB.et al. (2016). Comparative study on the effects between manual acupuncture and electroacupuncture for hemiplegia after acute ischemic stroke. Zhongguo Zhen Jiu36, 1121–1125. doi: 10.13703/j.0255-2930.2016.11.001
185
TianW.ZhuM.ZhouY.MaoC.ZouR.CuiY.et al. (2022). Electroacupuncture Pretreatment alleviates cerebral ischemia-reperfusion injury by regulating Mitophagy via mTOR-ULK1/FUNDC1 Axis in rats. J. Stroke Cerebrovasc. Dis.31:106202. doi: 10.1016/j.jstrokecerebrovasdis.2021.106202
186
TrompettoC.Currà A.PuceL.MoriL.SerratiC.FattappostaF.et al. (2019). Spastic dystonia in stroke subjects: prevalence and features of the neglected phenomenon of the upper motor neuron syndrome. Clin. Neurophysiol.130, 521–527. doi: 10.1016/j.clinph.2019.01.012
187
TurrigianoG. (2011). Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu. Rev. Neurosci.34, 89–103. doi: 10.1146/annurev-neuro-060909-153238
188
UnnisaA.GreigN. H.KamalM. A. (2023). Inhibition of caspase 3 and caspase 9 mediated apoptosis: a multimodal therapeutic target in traumatic brain injury. Curr. Neuropharmacol.21, 1001–1012. doi: 10.2174/1570159x20666220327222921
189
UrbinM. A.CollingerJ. L.WittenbergG. F. (2021). Corticospinal recruitment of spinal motor neurons in human stroke survivors. J. Physiol.599, 4357–4373. doi: 10.1113/jp281311
190
VidalS.BouzaherY. H.El MotiamA.SeoaneR.RivasC. (2022). Overview of the regulation of the class IA PI3K/AKT pathway by SUMO. Semin. Cell Dev. Biol.132, 51–61. doi: 10.1016/j.semcdb.2021.10.012
191
VijayN.MorrisM. E. (2014). Role of monocarboxylate transporters in drug delivery to the brain. Curr. Pharm. Des.20, 1487–1498. doi: 10.2174/13816128113199990462
192
ViraniS. S.AlonsoA.AparicioH. J.BenjaminE. J.BittencourtM. S.CallawayC. W.et al. (2021). Heart disease and stroke Statistics-2021 update: a report from the American Heart Association. Circulation143, e254–e743. doi: 10.1161/cir.0000000000000950
193
WahlA. S.BüchlerU.BrändliA.BrattoliB.MusallS.KasperH.et al. (2017). Optogenetically stimulating intact rat corticospinal tract post-stroke restores motor control through regionalized functional circuit formation. Nat. Commun.8:1187. doi: 10.1038/s41467-017-01090-6
194
WalterF.O’BrienA.ConcannonC. G.DüssmannH.PrehnJ. H. M. (2018). ER stress signaling has an activating transcription factor 6α (ATF6)-dependent "off-switch". J. Biol. Chem.293, 18270–18284. doi: 10.1074/jbc.RA118.002121
195
WalterP.RonD. (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science334, 1081–1086. doi: 10.1126/science.1209038
196
WangY.ChenY.MengL.WuB.OuyangL.PengR.et al. (2023a). Electro-acupuncture treatment inhibits the inflammatory response by regulating γδ T and Treg cells in ischemic stroke. Exp. Neurol.362:114324. doi: 10.1016/j.expneurol.2023.114324
197
WangZ.ChenX.ZhouL.WuD.CheX.YangG. (2003). Effects of extracellular signal-regulated kinase (ERK) on focal cerebral ischemia. Chin. Med. J.116, 1497–1503.
198
WangC.DengL.HongM.AkkarajuG. R.InoueJ.ChenZ. J. (2001). TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature412, 346–351. doi: 10.1038/35085597
199
WangD.LiL.ZhangQ.LiangZ.HuangL.HeC.et al. (2021). Combination of Electroacupuncture and constraint-induced movement therapy enhances functional recovery after ischemic stroke in rats. J. Mol. Neurosci.71, 2116–2125. doi: 10.1007/s12031-021-01863-1
200
WangY.LuM.LiuR.WangL.WangY.XuL.et al. (2023b). Acupuncture alters brain's dynamic functional network connectivity in stroke patients with motor dysfunction: a randomised controlled neuroimaging trial. Neural Plast.2023:8510213. doi: 10.1155/2023/8510213
201
WangJ.MaL.Afshari FardM. R.MohammadiA. (2021). Use of specific acupuncture techniques in lingering nummular eczema: a case report. J. Tradit. Chin. Med. Sci.8, 166–170. doi: 10.1016/j.jtcms.2021.03.001
202
WangJ. X.MaL. X.MuJ. D.SunT. Y.QianX.YuW. Y.et al. (2021). Anti-spastic effect induced by waggle needling correlates with KCC2-GABA(a) pathway in post-stroke spasticity rats. Neurosci. Lett.750:135810. doi: 10.1016/j.neulet.2021.135810
203
WangJ. X.MuJ. D.MaL. X.SunT. Y.QianX.YuW. Y.et al. (2020). Waggle needling wields preferable neuroprotective and anti-spastic effects on post-stroke spasticity rats by attenuating γ-aminobutyric acid transaminase and enhancing γ-aminobutyric acid. Neuroreport31, 708–716. doi: 10.1097/wnr.0000000000001471
204
WangX. Y.QianX.MaL. X.XiuJ. Y.MaL. H.ChenM. Y.et al. (2025). Effects of acupoints-based TENS at different frequencies plus tDCS on poststroke spastic hemiplegia: a randomized controlled trial. Am. J. Ther.32, e125–e134.
205
WardN. S.BrownM. M.ThompsonA. J.FrackowiakR. S. (2003). Neural correlates of motor recovery after stroke: a longitudinal fMRI study. Brain126, 2476–2496. doi: 10.1093/brain/awg245
206
WarisA.AliA.KhanA. U.AsimM.ZamelD.FatimaK.et al. (2022). Applications of various types of nanomaterials for the treatment of neurological disorders. Nanomaterials (Basel).12:2140. doi: 10.3390/nano12132140
207
WatanabeM.WakeH.MoorhouseA. J.NabekuraJ. (2009). Clustering of neuronal K+-cl- cotransporters in lipid rafts by tyrosine phosphorylation. J. Biol. Chem.284, 27980–27988. doi: 10.1074/jbc.M109.043620
208
WayneP. M.KrebsD. E.MacklinE. A.SchnyerR.KaptchukT. J.ParkerS. W.et al. (2005). Acupuncture for upper-extremity rehabilitation in chronic stroke: a randomized sham-controlled study. Arch. Phys. Med. Rehabil.86, 2248–2255. doi: 10.1016/j.apmr.2005.07.287
209
WhishawI. Q. (2000). Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat. Neuropharmacology39, 788–805. doi: 10.1016/s0028-3908(99)00259-2
210
WirthM.JoachimJ.ToozeS. A. (2013). Autophagosome formation--the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin. Cancer Biol.23, 301–309. doi: 10.1016/j.semcancer.2013.05.007
211
WisselJ.ManackA.BraininM. (2013). Toward an epidemiology of poststroke spasticity. Neurology80, S13–S19. doi: 10.1212/WNL.0b013e3182762448
212
WojkowskaD. W.SzpakowskiP.Ksiazek-WiniarekD.LeszczynskiM.GlabinskiA. (2014). Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis. Mediat. Inflamm.2014:590409. doi: 10.1155/2014/590409
213
World Health Organization (2002). Acupuncture: Review and analysis of reports on controlled clinical trials. Geneva: World Health Organization.
214
WuB.DingY.PengM.WangX.LiY.ChengX. (2023). Influence of acupuncture and other clinical factors on the recovery of limb motor function in patients after stroke: a retrospective study. J. Multidiscip. Healthc.16, 463–474. doi: 10.2147/jmdh.S398202
215
WuJ.LinB.LiuW.HuangJ.ShangG.LinY.et al. (2017). Roles of electro-acupuncture in glucose metabolism as assessed by 18F-FDG/PET imaging and AMPKα phosphorylation in rats with ischemic stroke. Int. J. Mol. Med.40, 875–882. doi: 10.3892/ijmm.2017.3057
216
WuH.MaJ.WangP.CorpuzT. M.PanchapakesanU.WyburnK. R.et al. (2010). HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol.21, 1878–1890. doi: 10.1681/asn.2009101048
217
WuW.TianW.HuZ.ChenG.HuangL.LiW.et al. (2014). ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep.15, 566–575. doi: 10.1002/embr.201438501
218
WuH.WeiH.SehgalS. A.LiuL.ChenQ. (2016). Mitophagy receptors sense stress signals and couple mitochondrial dynamic machinery for mitochondrial quality control. Free Radic. Biol. Med.100, 199–209. doi: 10.1016/j.freeradbiomed.2016.03.030
219
XiaZ.DickensM.RaingeaudJ.DavisR. J.GreenbergM. E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science270, 1326–1331. doi: 10.1126/science.270.5240.1326
220
XieH.GaoZ.FanY.ShiJ.TangY.ChaB.et al. (2022). Clinical observation of acupuncture combined with modern rehabilitation in the treatment of limb motor dysfunction after ischemic stroke: a randomized controlled trial. Medicine (Baltimore)101:e31703. doi: 10.1097/md.0000000000031703
221
XieG.SongC.LinX.YangM.FanX.LiuW.et al. (2019). Electroacupuncture regulates hippocampal synaptic plasticity via inhibiting Janus-activated kinase 2/signal transducer and activator of transcription 3 Signaling in cerebral ischemic rats. J. Stroke Cerebrovasc. Dis.28, 792–799. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.025
222
XinP.XuX.DengC.LiuS.WangY.ZhouX.et al. (2020). The role of JAK/STAT signaling pathway and its inhibitors in diseases. Int. Immunopharmacol.80:106210. doi: 10.1016/j.intimp.2020.106210
223
XingY.WangM. M.FengY. S.DongF.ZhangF. (2018a). Possible involvement of PTEN Signaling pathway in the anti-apoptotic effect of Electroacupuncture following ischemic stroke in rats. Cell. Mol. Neurobiol.38, 1453–1463. doi: 10.1007/s10571-018-0615-4
224
XingY.YangS. D.WangM. M.DongF.FengY. S.ZhangF. (2018b). Electroacupuncture alleviated neuronal apoptosis following ischemic stroke in rats via Midkine and ERK/JNK/p38 Signaling pathway. J. Mol. Neurosci.66, 26–36. doi: 10.1007/s12031-018-1142-y
225
XiongJ.ZhangZ.MaY.LiZ.ZhouF.QiaoN.et al. (2020). The effect of combined scalp acupuncture and cognitive training in patients with stroke on cognitive and motor functions. NeuroRehabilitation46, 75–82. doi: 10.3233/nre-192942
226
XuJ.PeiJ.FuQ. H.WangL. Y.ZhanY. J.TaoL. (2020). Earlier acupuncture enhancing long-term effects on motor dysfunction in acute ischemic stroke: retrospective cohort study. Am. J. Chin. Med.48, 1787–1802. doi: 10.1142/s0192415x20500895
227
YaoZ.CaiL.ZhaoA.YangL.ChenZ.ZhangY.et al. (2023). Electroacupuncture alleviates Neuroinflammation by regulating microglia polarization via STAT6/PPARγ in ischemic stroke rats. Neuroscience532, 23–36. doi: 10.1016/j.neuroscience.2023.09.007
228
YatsuF. M.LeeL. W.LiaoC. L. (1975). Energy metabolism during brain ischemia. Stability during reversible and irreversible damage. Stroke6, 678–683. doi: 10.1161/01.str.6.6.678
229
YttriE. A.DudmanJ. T. (2016). Opponent and bidirectional control of movement velocity in the basal ganglia. Nature533, 402–406. doi: 10.1038/nature17639
230
ZhanJ.PanR.ZhouM.TanF.HuangZ.DongJ.et al. (2018). Electroacupuncture as an adjunctive therapy for motor dysfunction in acute stroke survivors: a systematic review and meta-analyses. BMJ Open8:e017153. doi: 10.1136/bmjopen-2017-017153
231
ZhanY.PeiJ.WangJ.FuQ.XuJ.YanM.et al. (2023). Motor function and fALFF modulation in convalescent-period ischemic stroke patients after scalp acupuncture therapy: a multi-Centre randomized controlled trial. Acupunct. Med.41, 86–95. doi: 10.1177/09645284221086289
232
ZhangD.ArmstrongJ. S. (2007). Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis. Cell Death Differ.14, 703–715. doi: 10.1038/sj.cdd.4402072
233
ZhangY. Y.ChenQ. L.WangQ.DingS. S.LiS. N.ChenS. J.et al. (2022). Role of parameter setting in Electroacupuncture: current scenario and future prospects. Chin. J. Integr. Med.28, 953–960. doi: 10.1007/s11655-020-3269-2
234
ZhangY.LouH.LuJ.TangX.PangT.LeiS.et al. (2023). Scalp acupuncture alleviates cerebral ischemic stroke-induced motor dysfunction in rats via regulating endoplasmic reticulum stress and ER-phagy. Sci. Rep.13:10119. doi: 10.1038/s41598-023-36147-8
235
ZhangX.MaL.LiuM.ZhuT.HuangZ.XiongY.et al. (2023). "lifting Yang to dredging Du Meridian manipulation" acupuncture alleviates cerebral ischemia-reperfusion injury by mediating the NF-κB pathway. Brain Res.1816:148477. doi: 10.1016/j.brainres.2023.148477
236
ZhangF.WuY.JiaJ.HuY. S. (2010). Pre-ischemic treadmill training induces tolerance to brain ischemia: involvement of glutamate and ERK1/2. Molecules15, 5246–5257. doi: 10.3390/molecules15085246
237
ZhangP.ZhangY.ZhangJ.WuY.JiaJ.WuJ.et al. (2013). Early exercise protects against cerebral ischemic injury through inhibiting neuron apoptosis in cortex in rats. Int. J. Mol. Sci.14, 6074–6089. doi: 10.3390/ijms14036074
238
ZhangD.ZouW.ZhangB.GuoP. (2024). Scalp acupuncture for post-stroke spastic hemiparesis: a systematic review and meta-analysis. Medicine (Baltimore)103:e37167. doi: 10.1097/md.0000000000037167
239
ZhaoY.FangY.ZhaoH.LiJ.DuanY.ShiW.et al. (2018). Chrysophanol inhibits endoplasmic reticulum stress in cerebral ischemia and reperfusion mice. Eur. J. Pharmacol.818, 1–9. doi: 10.1016/j.ejphar.2017.10.016
240
ZhaoS.QuH.ZhaoY.XiaoT.ZhaoM.LiY.et al. (2015). CXCR4 antagonist AMD3100 reverses the neurogenesis and behavioral recovery promoted by forced limb-use in stroke rats. Restor. Neurol. Neurosci.33, 809–821. doi: 10.3233/rnn-150515
241
ZhengM.ChenR.ChenH.ZhangY.ChenJ.LinP.et al. (2018a). Netrin-1 promotes synaptic formation and axonal regeneration via JNK1/c-Jun pathway after the middle cerebral artery occlusion. Front. Cell. Neurosci.12:13. doi: 10.3389/fncel.2018.00013
242
ZhengT.JiangT.MaH.ZhuY.WangM. (2024). Targeting PI3K/Akt in cerebral ischemia reperfusion injury alleviation: from Signaling networks to targeted therapy. Mol. Neurobiol.61, 7930–7949. doi: 10.1007/s12035-024-04039-1
243
ZhengY.WangX. M. (2018b). Expression changes in lactate and glucose metabolism and associated transporters in basal ganglia following hypoxic-ischemic reperfusion injury in piglets. AJNR Am. J. Neuroradiol.39, 569–576. doi: 10.3174/ajnr.A5505
244
ZhongJ.ChanA.MoradL.KornblumH. I.FanG.CarmichaelS. T. (2010). Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil. Neural Repair24, 636–644. doi: 10.1177/1545968310361958
245
ZhouX.ChenH.WangL.LenahanC.LianL.OuY.et al. (2021). Mitochondrial dynamics: a potential therapeutic target for ischemic stroke. Front. Aging Neurosci.13:721428. doi: 10.3389/fnagi.2021.721428
246
ZhuG. C.ChenK. M.BelcastroF. (2024). Comparing the effects of different acupoint-stimulating therapies in mitigating post-stroke spasticity and motor dysfunction in older stroke survivors: a network meta-analysis of randomized trials. Maturitas187:108040. doi: 10.1016/j.maturitas.2024.108040
247
ZhuT.ZhouY.DaiA.LiS.ZhouL.ZhangX.et al. (2024). Efficacy of acupuncture and rehabilitation therapy on brain function activation area and neurological function in ischemic stroke: a systematic review and meta-analysis. PLoS One19:e0298547. doi: 10.1371/journal.pone.0298547
248
ZhuoY.XuM.DengS.ZhangY.LuX.WuB.et al. (2021). Efficacy and safety of dissimilar acupuncture intervention time-points in treating stroke: a systematic review and network meta-analysis. Ann. Palliat. Med.10, 10196–10212. doi: 10.21037/apm-21-1127
Summary
Keywords
ischemic stroke, pathogenesis, motor function, rehabilitation, acupuncture
Citation
He J-L, Ma L-X, Wen J-S, Zhuang Y-X, Qian X, Ma L-H, Xiu J-Y, Wang X-Y and Chen M-Y (2025) Potential impacts of acupuncture on motor function recovery after ischemic stroke: insights from basic and clinical studies. Front. Cell. Neurosci. 19:1623535. doi: 10.3389/fncel.2025.1623535
Received
06 May 2025
Accepted
29 July 2025
Published
13 August 2025
Volume
19 - 2025
Edited by
Ertugrul Kilic, Istanbul Medipol University, Türkiye
Reviewed by
Ahmet Burak Caglayan, University of Michigan, United States
Mustafa Caglar Beker, Istanbul Medeniyet University, Türkiye
Updates
Copyright
© 2025 He, Ma, Wen, Zhuang, Qian, Ma, Xiu, Wang and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Liang-Xiao Ma, maliangxiao@vip.sina.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.